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Abstract 
The γ-secretase complex is a proteolytic protein complex required for 
normal mammalian development, consisting of the components Presenilin-1/2, 
Aph-1, Nicastrin and Pen-2. Mutations in the genes encoding the proteins that 
form this complex have been linked to familial Alzheimer's disease. It has been 
known that this protein complex possesses proteolytic and non-proteolytic 
activity, but how these processes contribute towards the pathogenicity of 
Alzheimer's disease is not well understood. The social amoeba, Dictyostelium, 
has been used to research the Presenilin-1 component of the complex in 
Dictyostelium development and phagocytosis. However, results regarding Aph-
1, and Nicastrin have been controversial. Here, we utilise Dictyostelium to 
investigate the function of the γ-secretase complex. We investigate the 
homology between mammalian and Dictyostelium γ-secretase components, and 
the localisation of these components. We then describe the ablation of the 
Dictyostelium aph-1 gene, and demonstrate that Aph-1 and Nicastrin play 
functional roles in Dictyostelium development, and show that this role is 
dependent upon cell substrate. We also implicate the presenilin proteins as 
playing a role in Dictyostelium growth in liquid media. We go on to show that 
mutants lacking Presenilin, Aph-1 or Nicastrin show reduced fluid phase uptake 
by macropinocytosis. We propose that these defects may be due to 
dysfunctional vesicle acidification as γ-secretase mutant cells are highly 
sensitive to pH changes when undergoing development. Furthering this, we 
demonstrate that cells lacking Presenilin, Aph-1 or Nicastrin show aberrant 
autophagy, accumulation of high molecular weight ubiquitin aggregates, and 
dysfunctional phagocytosis. Additionally, we show that the acidification defects 
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observed upon Presenilin ablation can be rescued through expression of a 
human Presenilin 1 protein in Dictyostelium. Finally, we show that these 
processes are not dependent upon catalytic activity. This work demonstrates a 
role for the γ-secretase complex in vesicle acidification, through a non-catalytic 
mechanism, that is evolutionarily conserved from Dictyostelium to humans. 
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1.1 Alzheimer’s Disease 
Alzheimer’s disease (AD) is a neurodegenerative condition that results in 
cognitive decline, dementia decreased quality of life, and eventually death 
(Berchtold and Cotman, 1998). The disease affects roughly 46 million people 
worldwide (Anders et al., 2015), and as the ageing population increases the 
number of AD cases are also expected to rise with an estimated 131.5 million 
people affected by 2050  (Anders et al., 2015).  AD cases can be categorised into 
two different etiologies, sporadic AD where the patient exhibits no family history 
(Rebeck et al., 1993, Saunders et al., 1993), or familial AD where familial history, 
and target gene mutations are present (Citron et al., 1992, Scheuner et al., 1996). 
In 2013 dementia in the UK affected 1.3%, or 815,827 persons, with 62% of this 
due to AD, of these cases only 8% were due to familial Alzheimer’s disease (FAD) 
with the remainder being sporadic (Prince et al., 2014). These numbers are 
predicted to rise to 1.1 million people by 2025, and 2.2 million people by 2051 if 
the prevalence rates are steady (Prince et al., 2014, Anders and Prince, 2010) 
The total estimated costs of AD worldwide in 2015 were calculated to be $818 
billion, and would be the 18th largest economy in the world (Anders et al., 2015). 
In 2010, the highest costs are in high income countries such as Western Europe 
($210.12 billion) and North America ($213.04 billion) or $30,122 per patient and 
$48,605 per patient respectively (Anders and Prince, 2010). In the UK, the cost 
for 2013 were calculated at a total cost of £25.3 billion or £32,250 per patient with 
£4.3 billion on healthcare costs, £10.3 billion on social care and £11.6 billion in 
unpaid carers (Prince et al., 2014). The disease poses a significant burden to 
both, the ageing population, and the healthcare system worldwide. 
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1.2 The -secretase complex 
The -secretase complex is a protein complex consisting of four subunits: 
Presenilin (Psen); Anterior pharynx defective 1 (Aph-1); Nicastrin (Ncstn); and 
Presenilin enhancer 2 (Pen-2). The name -secretase was first used in 1993 
when describing the proteolytic activity that cleaves amyloid precursor protein 
(APP) in the transmembrane domain (Haass and Selkoe, 1993), and it wasn’t 
until 2003 when all of the components were identified (Strooper, 2003). The 
complex is responsible for the cleavage of a variety of single pass membrane 
proteins including amyloid precursor protein (APP) (De Strooper et al., 1998), 
Notch (De Strooper et al., 1999), erbB-4 (Ni et al., 2001), and E-cadherin 
(Marambaud et al., 2002).  
 
Figure 1.1 The -secretase complex. The intramembranous -secretase complex, showing the 
four subunits: The two transmembrane domain protein Pen-2 (red); the mutlipass protein 
Presenilin (orange) which undergoes endoproteolytic cleavage and subsequent activation; the 
single pass protein Nicastrin (green); and the mutlipass protein Aph-1 (blue).  
The substrates of the -secretase complex are involved in multiple processes and 
pathways within an organism (Parks and Curtis, 2007), such as the role of Notch 
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in neuron cell differentiation which is necessary for development of the brain and 
maintenance of neuronal progenitor cells (Bolos et al., 2007, Feller et al., 2008, 
Androutsellis-Theotokis et al., 2006). The role of other substrates such as APP is 
not fully understood but there is a substantial amount of evidence suggesting it 
plays a role in synaptic formation and repair where APP is upregulated during 
neuronal differentiation, and during neuronal repair (Phinney et al., 1999, Priller 
et al., 2006).  
Due to the large number of roles that -secretase substrates play in organisms, 
any mutations to complex components may disrupt not just embryonic 
development but also adult neuronal function, leading to disruption in a large 
number of vital processes. Therefore, it is important to understand the role of 
each component in this complex.   
1.2.1 Formation of the -secretase complex 
The complete formation of the -secretase complex has not yet been fully 
understood, however it is widely believed that all of the subunits of the complex 
are synthesised in the endoplasmic reticulum (ER) before being shuttled to the 
Golgi apparatus (Smolarkiewicz et al., 2013, De Strooper, 2003, Strooper, 2003). 
The synthesis and the formation of the complex has multiple different stages as 
each subunit joins the forming complex. Initially, nicastrin in a non-glycosylated 
form, referred to as immature nicastrin (imNcstn) binds to Aph-1 to assemble a 
stable heterodimer in the ER, Presenilin then joins this complex to form a three-
subunit protein complex before the final integration of Pen-2 (Mao et al., 2012, 
Fassler et al., 2011, Luo et al., 2003, Niimura et al., 2005). Once Pen-2 joins the 
complex Presenilin undergoes autoproteolysis therefore activating its catalytic 
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activity (Smolarkiewicz et al., 2013, Mao et al., 2012). Upon completion of the 
complex up to 5% of the complex is shuttled to the Golgi apparatus where 
Nicastrin then matures through glycosylation to form mature Nicastrin (mNcstn), 
the remainder stays within the endoplasmic reticulum as a reserve pool 
(Smolarkiewicz et al., 2013). Any components not part of this stable complex are 
degraded by lysosomes and endosomes. The final step involves the shuttling of 
active complexes (~5%) from the Golgi apparatus to the plasma membrane; 
inactive complexes remain shuttled between the Golgi apparatus and the ER 
(Smolarkiewicz et al., 2013). When positioned in the plasma membrane the 
catalytic domains are located within the plasma membrane itself allowing for 
intramembranous cleavage, the complex when localised to the ER is inactive, 
and active complexes are immediately shuttled out of the Golgi towards the 
plasma membrane (Smolarkiewicz et al., 2013). It is important to note that 
although a large portion of the complex is stored in the endoplasmic reticulum 
there are no known catalytic functions for -secretase in this sub-cellular 
compartment, but rather only on the plasma membrane and endosomes upon 
internalisation (Beel and Sanders, 2008). Additionally, although the complex does 
not have any catalytic activity in the endoplasmic reticulum it is proposed that it 
localises to the mitochondrial associated membrane and may affect mitochondrial 
function, however, this is not yet fully understood (Area-Gomez et al., 2009, 
Schon and Area-Gomez, 2010). 
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Figure 1.2 Formation of the -secretase complex. The four subunits of the -secretase 
complex are synthesised in the endoplasmic reticulum (ER), where Aph-1 (blue) and immature 
Nicastrin (imNcsctn, green) form a subcomplex before being joined by presenilin (orange) and 
finally Pen-2 (red) before being shuttled to the Golgi where nicastrin matures (mNcstn). This 
completed, matured, complex is then shuttled to the plasma membrane or broken down in 
endosomes and lysosomes. Some complex is recycled to the ER. Figure adapted from 
Smolarkiewicz et al. (2013) 
1.2.2 Presenilin  
In 1995 analysis of mutations present in patients with familial AD 
discovered two nine-transmembrane proteins with a large number of mutations 
giving rise to AD, that were then named Presenilin 1 (Sherrington et al., 1995) 
and Presenilin 2 (Levy-Lahad et al., 1995). At the same time, a separate group 
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showed the involvement of presenilin in regulating the Notch signalling pathway 
in Caenorhabditis elegans (Levitan and Greenwald, 1995), therefore implicating 
the presenilin proteins not only in AD pathogenesis but also in embryonic and 
neural development via its interaction with Notch. The exact mechanism in which 
these two pathways were linked however was not fully understood. 
The role of the presenilin proteins in AD was not clear until experiments in patient 
derived fibroblasts demonstrated that Presenilin mutations found in familial 
Alzheimer’s disease (FAD) resulted in abnormal amyloid precursor protein (APP) 
cleavage and subsequent neurotoxic Amyloid- (A)generation (Scheuner et al., 
1996) and their function was further elucidated through overexpression of mutant 
presenilin proteins in cultured cell lines and in vivo mouse models (Borchelt et al., 
1997, Borchelt et al., 1996). Further support for this was shown using neurons 
derived from Psen1 knockout mice to show that the generation of all A peptides, 
and not just abnormal forms was disturbed (De Strooper et al., 1998). The role of 
the presenilin proteins in both Notch signalling and APP cleavage was discovered 
when it was shown that -secretase inhibitors blocked both APP processing and 
Notch cleavage suggesting the complex was responsible for both effects, and 
therefore simply inactivating the complex as a treatment for AD was not possible 
due to resultant defects in Notch signalling (De Strooper et al., 1999). 
The presenilins were first identified as the catalytic core of the -secretase 
complex, after undergoing endoproteolytic cleavage, when aspartyl residues 
within transmembrane domain 6 and transmembrane domain 7 were mutated 
resulting in abolished protein cleavage (Wolfe et al., 1999) demonstrating that the 
presenilins function as an aspartyl protease within the -secretase complex. It is 
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also worth noting that the aspartyl residues present in the human presenilins TMD 
6 and 7 are conserved across different species including P. patens and 
Dictyostelium (Khandelwal et al., 2007, Ludtmann et al., 2014, Otto et al., 2016). 
Mutation of these key catalytic residues does not change the expression or 
incorporation of Presenilin into the -secretase complex (Nyabi et al., 2003), as 
catalytically inactive Presenilin is still able to incorporate into the complex 
suggesting that the catalytic activity is not necessary for Presenilin integration 
into the -secretase complex. 
Although the main function of the presenilins is believed to provide the catalytic 
subunits of the -secretase complex, a number of different roles have also been 
suggested, such as roles in protein trafficking (Zhang et al., 2006), calcium 
homeostasis (Lee et al., 2015) and -catenin signalling (De Strooper et al., 2012). 
These roles have been shown using presenilins with substituted aspartyl residues 
or non-catalytic presenilin mutants demonstrating that certain presenilin functions 
are not dependent on the catalytic activity. 
1.2.3 Anterior Pharynx Defective 1 
It was not until 2002 that the 7-transmembrane domain Anterior Pharynx 
Defective 1 (Aph-1) was implicated in the Notch signalling pathway in C. elegans. 
Aph-1 showed similar function and localisation to the presenilin genes, being 
required for the proper cell surface localisation of Nicastrin (Goutte et al., 2002). 
In 2003, it was shown that Aph-1 was required to enable a fully matured and 
active -secretase complex, where overexpression causes an accumulation of 
full-length presenilin and loss of function showed downregulated presenilin and 
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nicastrin (in vitro), and a Notch phenotype in C. elegans (Goutte et al., 2002, 
Strooper, 2003). 
There are two different genes encoding for Aph-1 in humans, Aph-1A and Aph-
1B, with a duplication of the B-type in mice giving rise to a third, Aph-1C (Serneels 
et al., 2005). These different Aph-1 proteins, whilst sharing a name and potential 
common function, do have some differences in the way that they contribute to the 
function of the -secretase complex in vivo. Analysis of Aph-1A-/-, B-/-, C-/- and BC-
/- mice show that although the proteins are extremely similar in sequence the 
phenotypes in respective deficient mice differ (Serneels et al., 2005). Aph-1 A-/- 
mice were embryonically lethal showing defective angiogenesis in the yolk sac, 
neuronal tube malformations and somitogensis defects, the remaining deficient 
mice (B-/-, C-/-, BC-/-) survived until adulthood but showed decreased APP 
processing in the adult brain.  
Aph-1A and Aph-1B share a number of conserved domains and residues that are 
important for protein function. The GxxxGxxxG motif has been shown to be 
important for the binding and incorporation of Aph-1 to nicastrin and the -
secretase complex (Lee et al., 2004b). Mutations in any of the glycine residues 
at positions 122, 126 and 130 in humans results in an unstable Aph-1-Nicastrin 
holocomplex and suggests that Aph-1 has a scaffolding role in the initial assembly 
and maturation of an active -secretase complex (Lee et al., 2004b). Mutations in 
the GxxxG domain in C. elegans, at position 123 leads to a complete Notch loss 
of function phenotype suggesting that the -secretase complex is not able to form 
if this motif is mutated (Goutte et al., 2002).  
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The role that Aph-1 plays within the -secretase complex however is still not fully 
understood. Aph-1 has been suggested to have an active role, responsible for 
regulation of the endoproteolysis of presenilin (Luo et al., 2003). Aph-1 has also 
been suggested to have a non-active, role in stabilising the -secretase complex 
(Takasugi et al., 2003). As recently as 2010 a new role was suggested for Aph-1 
in directly associating with both full-length and C-terminal fragments of -
secretase substrates in both Chinese hamster ovary and human embryonic 
kidney cells, even under complex denaturing conditions (Chen et al., 2010). This 
study further showed that mutation of conserved histidine residues in either 
positions 171 or 197 resulted in association with less APP, and the double mutant 
showed an even greater deficiency despite all three histidine mutants binding and 
incorporating to the -secretase complex (Chen et al., 2010).    
1.2.4 Nicastrin 
Nicastrin is the largest component of the -secretase complex. It is a single pass 
membrane protein that initially forms a holocomplex with Aph-1 in its immature 
110kDa form before maturing to a highly glycosylated 130 kDa form when the -
secretase complex matures (De Strooper, 2003, Smolarkiewicz et al., 2013). First 
found to modulate presenilin-mediated notch signalling in C.elegans, nicastrin 
null mutations resulted in a notch deficient phenotype in C. elegans, as well as 
an increase in A42/40 secretion in human embryonic kidney (HEK) cells (Yu et 
al., 2000). 
The function of Nicastrin within the -secretase complex is a research area full of 
conflicting theories. It has been suggested that Nicastrin functions as a substrate 
recognition component prior to cleavage, with glutamate at position 333 providing 
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an amino acid for this function (Shah et al., 2005). However, this role was 
disputed as the same glutamate (Glu332 in mouse Nicastrin) was required for 
maturation of the -secretase complex, but played no role in the recognition of 
substrates (Chavez-Gutierrez et al., 2008). Further complications then arose as 
it was found that nicastrin -/- mutants were able to cleave Notch and APP in two 
separate independent mouse embryonic fibroblast (MEF) lines in the presence of 
proteasome inhibitors, suggesting a potential stabilisation role rather than an 
active role within the complex in either substrate recognition or maturation (Zhao 
et al., 2010). Finally, nicastrin may play a role in synaptic function in hippocampal 
neurons independent of the -secretase complex. Conditional nicastrin mouse 
knockouts have deficiencies in presynaptic plasticity, a phentotype blocked by 
the depletion of Ca2+ suggesting that calcium homeostasis underlies these 
presynaptic deficits (Lee et al., 2014). These finding suggests that nicastrin may 
have a role independent of -secretase in regulation of synaptic function, however 
its role within the complex is still an area of debate.  
1.2.5 Presenilin Enhancer 2 
Pen-2 is the smallest component of the -secretase complex, and the final 
member to be incorporated into the complex (Mao et al., 2012). Pen-2 is a 
multipass membrane protein with two transmembrane domains and the function 
of the protein remains unclear. In 2003 Pen-2 was shown to regulate the 
proteolytic processing of the presenilins as reduced Pen-2 levels resulted in 
reduced production of Presenilin CTF, showing only full length Presenilin (Luo et 
al., 2003). More recent research has demonstrated that Pen-2 is dispensible for 
presenilin endoproteolysis as in the presence of proteasome inhibitors, Presenilin 
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was capable of endoproteolysis in MEFs independently of Pen-2 (Mao et al., 
2012).  
Mutations in different regions of the Pen-2 protein result in different effects on the 
-secretase complex, showing conserved regions across several species 
(Holmes et al., 2014). These conserved regions include, within the N-terminal 
domain N8 where a mutation results in an increase of A40/42 production by 
300% and 180% respectively; and amino acid mutations K11A/K17A which 
results again in increased Aproduction. Mutations within the first half of TMD1 
reduced A production with the greatest effects from mutations of F25/L26, 
resulting in a decrease by 30-50% compared to wild type. Mutations in the second 
half of TMD1 elevated A production by up to two-fold compared to wild type. 
Mutations in the loop region, I53A, V57A and K54A reduced A40 production with 
no changes to the 42 form. TMD2 mutations however seemed to have moderate 
effects causing only slight decreases in both forms of A. Finally, in the C-terminal 
domain a loss of D90 results in both Aforms increasing in secretion by 160%, 
whilst converting it to a positively charged amino acid results in reduced secretion 
of both species to about 50% (Holmes et al., 2014). In the absence of any 
detectable Pen-2 there is still a minor amount of presenilin endoproteolysis in the 
presence of proteasome inhibitors (Holmes et al., 2014). These data taken 
together suggest that Pen-2 may act as a catalyst for presenilin endoproteolysis, 
and as a stabilisation factor that allows for full assembly and complete trafficking.  
1.2.6 -secretase protease activity 
The protease activity of -secretase is dependent on catalytic aspartyl 
residues in the presenilin proteins which proteolytically process single 
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transmembrane domain substrates which are implicated in a number of different 
processes within a cell, and number up to 91 different proteins (Haapasalo and 
Kovacs, 2011). These processes include transcriptional regulation, regulation of 
cell fate, cell death, neurite outgrowth and cell adhesion, regulation of 
angiogenesis and tumorigenesis (Haapasalo and Kovacs, 2011).  
Several -secretase substrates have been implicated in transcriptional regulation. 
The transcriptional function of these substrates is most often suggested due to 
their nuclear localisation and ability to affect transcription in assays, these 
include: alcaidens (Araki et al., 2004); CD44 (Okamoto et al., 2001); Notch 
(Schroeter et al., 1998) and its ligands Delta and Jagged (Ikeuchi and Sisodia, 
2003), E-cadherin (Marambaud et al., 2002) and receptor-like protein tyrosine 
phosphatases (Anders et al., 2006). The intracellular domains of all of these 
substrates generated by cleavage by -secretase serve as regulatory switches in 
their downstream activity (Haapasalo and Kovacs, 2011). This has been 
demonstrated in the full-length forms of E-cadherin which is usually involved in 
cell-cell adhesion whereas the intracellular domain generated has been shown to 
regulate transcription after nuclear localisation (Marambaud et al., 2002). Notch, 
a -secretase substrate, has been shown to regulate cell fate through its 
transcriptional activity (Fiuza and Arias, 2007). Notch achieves transcriptional 
regulation by releasing the Notch intracellular domain (NICD) after ligand binding 
which then localises to the nucleus and targets the recombining binding protein 
suppressor of hairless (RBP-J) thereby activating previously supressed 
transcription (Shawber et al., 1996, Castel et al., 2013). Other substrates 
regulated with cell fate regulation include receptor tyrosin-protein kinase ErbB4 
(ErbB4), which upon cleaveage releases the ErbB4-ICD implicated in nuclear 
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translocation and pro-apoptotic activity, whereas the ErbB4 protein has been 
shown to have a role in cell fate determination in the brain (Linggi et al., 2006).  
Neuronal cell death is considered a cause of Alzheimer ’s disease progression, 
and the intracellular domain of p75 neurotrophin receptor, a -secretase 
substrate, has been implicated in neurotrophin-mediated death signalling in 
neurons where it was shown that brain-derived neurotrophic factor induces the 
generation of the p75 neurotrophin receptor intracellular domain by -secretase 
and subsequent apoptotic signalling (Majdan et al., 1997). 
The proteolytic activity of -secretase has also been implicated in human disease, 
most notably Alzheimer’s disease through the cleavage of APP to generate the 
small 36 – 43 peptide Amyloid  proteins including the two toxic 42 and 43 forms 
(Scheuner et al., 1996, Borchelt et al., 1996). This proteolytic pathway is the basis 
of the amyloid cascade hypothesis in AD progression which states that the toxic 
A fragments aggregate upon generation and cause senile plaques indicative of 
the condition which are thought to arise due to mutations in the catalytic presenilin 
proteins (Scheuner et al., 1996). A second pathway is present for the processing 
of APP, known as the non-amyloidogenic pathway as it does not culminate with 
the production of A fragments, in this pathway the initial cleavage of APP is 
carried out by -secretase as opposed to -secretase therefore exposing 
different CTF cut sites to -secretase resulting in the generation of p3 instead of 
A 
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1.2.7 Scaffolding activity of -secretrase 
Aside from the well-established proteolytic role of the -secretase complex there 
have been a number of studies investigating the non-proteolytic functions of the 
complex. These functions include roles in protein trafficking and turnover 
(Esselens et al., 2004), calcium homeostasis (Lee et al., 2015, Begley et al., 
1999, Keller et al., 1998) and in the regulation of -catenin (Kang et al., 1999). 
These non-proteolytic roles have been shown in a number of different studies. 
Presenilin 1 has been shown to bind to -catenin, which is not a proteolytic 
substrate of -secretase, in both transfected EcR293 cells and in the brains of 
transgenic mice (Kang et al., 1999). This interaction between PS and -catenin 
lead to an increased association of -catenin with GSK3when PS1 was 
overexpressed which subsequently resulted in increased turnover of -catenin as 
GSK3 is a negative regulator (Kang et al., 1999). Further, the half-life of -
catenin was greatly increased in fibroblasts that were PS1 deficient which was 
overcome by reconstitution of catalytically inactive PS1 demonstrating a non-
catalytic protein turnover function of PS1 in the -secretase complex (Kang et al., 
1999).  
Two independent studies in 1999 and 1998 demonstrate that -secretase 
functions in calcium homeostasis and dysfunctional calcium homeostasis 
resulted in mitochondrial dysfunction and toxin-induced apoptosis in neuronal 
cells. In rat adrenal medulla (PC12) cells expressing FAD mutant Psen1 (L286V) 
are more sensitive to apoptosis induced by 3-nitropropionic acid and oxyradical 
production than wild-type cells, which is associated with elevated levels of Ca2+, 
and subsequent mitochondrial failure which could be reversed through reduction 
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of cytoplasmic calcium levels (Keller et al., 1998), suggesting that these presenilin 
mutations are involved in aberrant calcium regulation and oxidative stress. 
Additionally, synaptosomes prepared from FAD Psen1 mutation harbouring mice 
showed elevated levels of cytoplasmic calcium compared with synaptosomes 
from nontransgenic mice and mice overexpressing wild-type Psen1 (Begley et 
al., 1999). The mitochondrial dysfunction after metabolic insults was more potent 
in these FAD Psen1 mutant mice synaptosomes when compared to wild type 
mice and, once again, these results could be reversed through the use of buffered 
cytoplasmic calcium or using agents that prevented the release of Ca2+ from the 
endoplasmic reticulum (Begley et al., 1999). 
These various studies suggest that the -secretase complex does not just have a 
proteolytic role but also a variety of non-proteolytic roles as catalytically inactive 
complexes are capable of restoring wild-type phenotypes. These studies further 
demonstrate that mutations in Psen1 that affect the cleavage of APP may not be 
the only way in which the -secretase complex can contribute to the pathogenesis 
of AD. Finally, a number of these roles are conserved across various species and 
organisms (Otto et al., 2016).  
1.3 Alzheimer’s Disease Theories 
Numerous theories have been proposed for the causes of AD, each with a 
substantial amount of evidence to lend credence to them. There are four major 
theories which will be discussed here, these are the amyloid cascade hypothesis 
(Borchelt et al., 1997), the tau hypothesis (Ittner and Gotz, 2011), the Glycogen 
Synthase Kinase 3 hypothesis (Hooper et al., 2008), and the dysfunctional endo-
lysosomal system hypothesis (Hu et al., 2015, Menzies et al., 2015). However, 
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despite these four hypotheses being seemingly independent, it is important to 
note that AD is most likely a multifactorial condition and each of these conditions 
may contribute to the overall disease.  
1.3.1 Amyloid cascade hypothesis 
The most common theory for Alzheimer’s disease pathology is the amyloid 
cascade hypothesis, where aberrant cleavage of the protein amyloid precursor 
protein results in neurotoxic plaque formation in the brain (Citron et al., 1992). 
Amyloid Precursor Protein is a single pass transmembrane protein that is cleaved 
sequentially by two proteases, -secretase, generating a fragment known as 
CTF-, and -secretase which generates a small 36 – 43 amino acid protein 
known as Amyloid-, A(Nunan and Small, 2000). Two forms of Aare thought 
to be toxic, these are the 42 and 43 amino acid forms (A42 and A43). The exact 
reason behind the production of these two toxic forms of A is not fully 
understood, but is thought to be due to mutations in the -secretase that cleaves 
CTF-(Zhang et al., 2011). 
The amyloid cascade hypothesis follows the production of these two toxic forms 
of A and suggests that A42 and A43 may aggregate and self-polymerise to 
form extracellular plaques in AD patient brains (termed senile plaques) (Tanzi, 
2005). This theory has been successfully demnostrated in the brains of mouse 
and fruit fly models (Iijima et al., 2004) and in human AD patients where plaque 
formation results in neuronal death (Gregory and Halliday, 2005). 
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Figure 1.3. A schematic of -secretase proteolytic activity. When amyloid precursor protein 
(APP) undergoes proteolytic processing, there are two separate pathways depending on the 
initial cleavage. The amyloidogenic pathway (right) arises from a cleavage of APP by -
secretase generating secreted APP (S-APP) and a -CTF. This is then subsequently cleaved by 
-secretase to generate an amyloid intracellular domain (AICD) and amyloid  (A) fragments 
which aggregate to form characteristic senile plaques in Alzheimer’s disease patient brains. The 
second pathway is the non-amyloidogenic pathway (left) which arises from APP cleavage by -
secretase and subsequent cleavage by -secretase generating an AICD and p3.  
It is worth noting however that not all studies support the senile plaques as a 
cause of AD. Evidence has suggested that the deposition of A may be a 
neuroprotective response to AD (Lee et al., 2004a).  
1.3.2 Tau Phosphorylation Hypothesis 
Tau is a protein associated with microtubules in neurons in humans. These 
proteins are responsible for the stability of the axon microtubules and play an 
important role in the human brain (Harada et al, 1994). Upon 
28 
 
hyperphosphorylation Tau is no longer able to stabilise axonal microtubules 
leading to neuronal death (Trojanowski and Lee, 2005). Histopathalogical studies 
of AD patient brain samples showed hyperphosphorylated tau aggregates termed 
neurofibrillary tangles (NFTs) (Ittner and Gotz, 2011). These 
hyperphosphorylated NFTs are spread throughout the brain and appear to show 
the progression and severity of AD in the patient, they also show synaptic loss in 
the patient brain (Ittner and Gotz, 2011).  
1.3.3 Glycogen Synthase Kinase 3 
Deregulation of the kinase Glycogen Synthase Kinase 3 (GSK3) may also 
be a causative factor for the pathogenesis of AD (Hooper et al., 2008). This model 
suggests that the deregulation of GSK3 results in the hyperphosphorylation of 
tau, memory impairment and increased production of A. The rationale behind 
this is due to the evidence that GSK3 has been shown to colocalize with 
dystrophic neurites and the characteristic neurofibrillary tangles observed in AD 
patient brains as well as the presence of GSK3 in pre-tangle neurons, 
hippocampus and frontal cortex of AD patients (Hooper et al., 2008). In addition, 
a polymorphism in the GSK3 promoter has also identified as a risk factor for AD 
(GSK3 -50TT genotype) (Mateo et al., 2006). Finally, GSK3 inhibitors show 
benefits in AD model neurodegeneration, reducing amyloid inflammation and 
neurotoxicity in hippocampal neuronal cultures (Hu et al., 2009), however more 
research has to be done into this pathway before anything conclusive can be 
said. 
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1.3.4 Endo-lysosomal and Vesicle Trafficking System 
The Presenilin proteins and -secretase complex have been implicated in 
mediating mammalian endocytosis and autophagy, potential contributing factors 
in Alzheimer’s disease (Lee et al., 2015, Lee et al., 2010, Neely et al., 2011, 
Cataldo et al., 2000, Tamboli et al., 2008, Zhang et al., 2006). Mammalian cells 
lacking Presenilin proteins show decreased endocytosis, taking up lower levels 
of lipoprotein transporters and subsequent increased levels of apolipoprotein E 
(Tamboli et al., 2008). Additionally, cells have decreased clearance from 
endocytic compartments and increased protein deposition (Zhang et al., 2006). 
Presenilin has also been implicated in autophagy, the process through which cells 
break down intracellular components. Mammalian cells lacking Presenilin, or with 
AD-causing mutations, demonstrate increased autophagosome accumulation, 
and decreased protein clearance (Lee et al., 2010, Neely et al., 2011). It has been 
proposed that these defects in protein clearance result in the accumulation and 
aggregation of A, and that these defects precede the characteristic 
neurofibrillary tangles, and amyloid plaques (Ghavami et al., 2014, Hu et al., 
2015, Wolfe et al., 2013). 
It has been suggested that defects in the endocytic and autophagic pathway are 
due to more basic lysosomal pH conditions (Dobrowolski et al., 2012, Lee et al., 
2015, Lee et al., 2010, Wolfe et al., 2013). Ablation of presenilin results in a more 
basic lysosomal pH suggesting that presenilin mediates lysosomal pH through 
calcium regulation and homeostasis (Lee et al., 2015). Additionally, these studies 
are unable to differentiate between effects observed upon presenilin ablation or 
due to lack of -secretase activity as a whole. 
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1.3.5 Other theories 
There are several other potential AD causing theories than the ones 
mentioned above. These include the cholinergic hypothesis, biometals 
hypothesis, retrogenesis hypothesis and the spirochetosis theory which shall all 
be discussed below.  
The cholinergic hypothesis is one of the oldest theories for AD and has a 
number of treatments based upon it (Francis et al., 1999). This theory suggests 
that deficits in excitatory amino acid neurotransmission and in cholinergic 
system processing, due to cholinergic neuronal loss, result in the observed 
decline of memory and learning in AD patients (Davies and Maloney, 1976, 
Perry et al., 1978, Bartus et al., 1982). Several therapies have been based upon 
the cholinergic hypothesis especially the use of acetylcholinesterase inhibitors 
(Martorana et al., 2010), however, the efficacy of these drugs leaves much to be 
desired. Currently, these treatments do show some improvement in memory 
and cognitive function throughout AD progression, however these changes are 
unlikely to be solely due to acetylcholine upregulation suggesting that decline in 
memory and cognitive function are due to a complex interaction of several 
different neurotransmitters (Martorana et al., 2010). 
The biometals theory is a more controversial theory than those previously 
discussed. This theory posits that the cellular homeostasis of biometals is 
disrupted in cases of AD, especially exposure to and the levels of aluminium 
(Exley, 2007, Rodella et al., 2008, Bondy, 2016, Kandimalla et al., 2016, 
Kastenholz et al., 2009, Xu et al., 2014). The biometals theory proposes that 
these metal ions affect, and are in turn, affected by several other AD related 
proteins such as apolipoprotein E (Xu et al., 2014), and tau (Exley, 2007) 
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thereby causing oxidative stress that may contribute to AD progression (Su et 
al., 2008). This theory does however have several opponents (Lidsky, 2014) 
with the quality of the research being criticised (Lidsky, 2014, Santibanez et al., 
2007). 
The retrogenesis hypothesis is based upon the idea that as foetuses undergo 
neurodevelopment people with AD undergo a reverse process resulting in 
progressive cognitive decline first suggested by Reisberg (Reisberg et al., 
1999a, Reisberg et al., 1999b, Alves et al., 2015). However, the retrogenesis 
theory has not been extensively investigated.  
The final AD causing theory to be discussed here is the spirochetosis theory. It 
has been established that spirochetal infection may be a causative factor of 
progressive dementia, brain atrophy and amyloid deposition, especially in cases 
such as syphilis or Lyme disease (MacDonald, 1986, Dupuis, 1988, Schaeffer 
et al., 1994, Miklossy, 1993). More recently, research has begun to implicate 
spirochetosis and AD, as spirochetes may be present in the brains of AD 
patients (Miklossy, 2011, Riviere et al., 2002, MacDonald, 2006). Additionally, 
within the senile plaques characteristic of AD progression researchers have 
discovered the presence of biofilms (Allen, 2016), this theory postulates that the 
innate immune system cannot penetrate the biofilm and destroy the spirochetes 
forming these biofilms and instead destroy the surrounding tissue (Allen, 2016). 
The destruction of the surrounding brain tissue results in the characteristic 
neurodegeneration and brain atrophy found in AD patient brains. 
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1.4 Models used for AD research 
Current models used in Alzheimer’s disease include the usual model 
organisms such as transgenic mice (Begley et al., 1999, Majdan et al., 1997, 
Borchelt et al., 1997, Meckler et al., 2010), mammalian cell lines, e.g. HEKs and 
MEFs (Nyabi et al., 2003, Chavez-Gutierrez et al., 2008, De Strooper et al., 1999, 
Strooper, 2003) and other slightly unusual model organisms such as the moss 
Physcomitrella patens (Khandelwal et al., 2007).  
With the use of each model organism there are a number of advantages and 
disadvantages, for example in mouse models it is necessary to note that animals 
do not present neuronal loss observed in AD patients, but show a loss of 
synapses which precedes the neuronal loss (Cuadrado-Tejedor and Garcia-Osta, 
2014). Additionally, in mouse models you cannot generate a complete -
secretase complex null line in mice, or other whole animal models such as C. 
elegans, as any non-functional complex results in embryonic lethality due to the 
importance of Notch, a vital component of embryonic development (Serneels et 
al., 2005, Goutte et al., 2002). This means that no true null lines can be generated 
and only knock downs, or conditional knock outs, which may lead to residual 
levels of these components that may still be able to carry out their required 
function. Mammalian cell lines are also diploid in nature, with two copies of each 
gene, making genetic manipulation and gene ablation much more difficult than in 
haploid model organisms. Plant models such as P. patens used by Khandelwal 
et al in 2007 do have some advantages over animal models. P. patens does not 
express Notch, APP or ErbB4 and so are not affected by the dominant loss of 
Notch lethal phenotype seen in animal models, but do demonstrate a non-
proteolytic loss of -secretase activity phenotype with regards to an inability to 
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respond light which can be rescued by expression of human presenilin 
(Khandelwal et al., 2007) indicating conservation of function between these two 
organisms.  
1.5 Dictyostelium discoideum 
Dictyostelium discoideum is a single celled amoeba first discovered in 
1935 by K.B. Raper (Raper, 1935). The organisms inhabits forest floors and 
survives by ingesting bacteria through phagocytosis (Boeckeler and Williams, 
2001). Upon starvation Dictyostelium begin to undergo multicellular development. 
This development process begins when starving cells begin to secrete cyclic AMP 
(cAMP) and chemotax towards the secreted cAMP where they form a mound and 
then the final developmental structure, a fruiting body. This fruiting body will 
contain a spore head filled with viable Dictyostelium spores to ensure survival 
(Williams et al., 2006). 
This developmental process can be broken down into several stages, the first of 
which is aggregation. In this stage, the single cells will begin to chemotax towards 
cells secreting cAMP through G-protein coupled receptor activation (McMains et 
al., 2008) until ~105 cells have come together at a central point called the mound, 
the second stage. Once the mound has been formed cells begin to undergo 
differential gene expression becoming either pre-spore or pre-stalk cells 
(Williams et al., 2006). The third stage, the slug, occurs after the differentiation of 
pre-spore and pre-stalk cells is completed. Cells with pre-determined cell fates 
will form a multicellular slug consisting of pre-stalk cells in the anterior and pre-
spore cells in the posterior (MacWilliams and Bonner, 1979). Culmination is the 
final step in Dictyostelium development and consists of the pre-stalk cells forming 
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a stalk of non-viable cells, and the pre-spore cells forming a spore head atop the 
stalk (Jang and Gomer, 2011). The ultimate structure is the Dictyostelium fruiting 
body which is approximately 1mm in height and consists of three separate 
structures: the basal disc, the stalk and the spore head (Williams et al., 2006). 
1.6 Dictyostelum discoideum as a biomedical model 
Whilst its natural habitat is damp forest floors, Dictyostelium has also been 
used as a biomedical model. The cells are able to be easily maintained at a 
constant 22°C in liquid media ingesting nutrients through macropinocytosis and 
double approximately every 8 hours in laboratory conditions, allowing for high 
throughput research.  
The development of DNA-transformation techniques using Dictyostelium (Nellen 
et al., 1984) was a major step forward for the use of this organism as a biomedical 
model, and the full sequencing of the 34Mb, 6 chromosome, genome has only 
aided this (Eichinger et al., 2005). Upon sequencing of the genome, it was 
discovered that 64 of 287, or ~32%, of queried human disease genes share 
homology to Dictyostelium counterparts and has allowed the organism to be used 
in a variety of studies relating to human drug target, and intracellular pathway 
analysis (Eichinger et al., 2005, Williams et al., 2006). One major advantage of 
using Dictyostelium as a model as opposed to other single celled biomedical 
models is the possession of several genes and targets that are lacking in other 
biomedical models, such as Saccharomyces cerevisiae (Eichinger et al., 2005). 
A wide variety of methodologies has allowed Dictytostelium to be used to 
investigate a multitude of human diseases. These include, gene manipulation 
through ablation and overexpression in isogenic cell lines, developmental assays, 
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chemotaxis studies, and mutant library screening. All of these methods can be 
used to determine the effects of compounds of interest on the organism, therefore 
finding potential targets, or for the effects of gene ablation or overexpression and 
the resulting phenotypic defects in the model (Boeckeler and Williams, 2001).  
The organism has been used until now to investigate the effects of valproic acid 
and lithium bipolar disorder and epilepsy (Terbach et al., 2011, Chang et al., 
2012, King et al., 2009), and to help further the understanding of Alzheimer’s 
disease (McMains et al., 2010, Ludtmann et al., 2014), mitochondrial disease 
(Francione et al., 2011), and Schwachman-Diamond syndrome (Wong et al., 
2011).  
1.6.1 Dictyostelium discoideum in -secretase research 
Dictyostelium has been used to better determine the basal function of the 
complex and its components despite lacking any known -secretase substrates. 
The organism has been used to investigate the entire -secretase complex 
showing that the Dictyostelium complex is able to cleave a truncated version of 
human APP (consisting of only the C-terminal 240 amino acids) expressed in 
Dictyostelium and release A peptides (McMains et al., 2010). Additionally, 
inhibitors of -secretase activity are able to partially inhibit the processing of APP 
by Dictyostelium-secretase (McMains et al., 2010). The Dictyostelium -
secretase complex is also able to cleave the human Notch protein (Ludtmann et 
al., 2014). The ability of the Dictyostelium complex to cleave human substrates, 
but not have any known endogenous substrates, may suggest that the -
secretase complex and its function has been evolutionarily conserved, and so 
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may have a different role perhaps in one of the other areas such as scaffolding, 
protein trafficking or calcium homeostasis.  
The Dictyostelium -secretase complex has also been implicated in Dictyostelium 
phagocytosis and development. Psen1-, and Psen1-/2- mutants showed defective 
growth on bacteria under laboratory conditions when compared to wild type 
strains with double mutants showing more severe growth defects when compared 
to single mutants demonstrated by smaller cleared plaques (McMains et al., 
2010), however, it is also important to note that these defects may be observed 
as a result of decreased cell motility. Cell lines lacking -secretase components 
also showed development defects, each mutant showed different phenotypes 
depending on which component was ablated, Psen2-, Aph-1- and Ncstn- cells all 
exhibited defects in late development extending the amount of time spent in the 
migratory slug stage, and a decreased amount of viable spores whilst Psen1- null 
cells completed development along with wild type within ~24 hours (McMains et 
al., 2010). Double mutants consisting of Psen1-/2-, Aph-1-/Psen2- and Ncstn-
/Psen2- lines showed a similar phenotype to their corresponding single knock outs 
with the double Psen1-/2- knockout being the most drastic suggesting that the -
secretase complex plays a role in late development of Dictyostelium (McMains et 
al., 2010). However, the roles of the -secretase components in Dictyostelium 
development are controversial, a subsequent study showed that single Psen 
mutants did not show any developmental defects, nor did a Ncstn- cell line 
suggesting a presenilin-only complex independent role in development 
(Ludtmann et al., 2014). Additionally, expression of the human Psen1 in the 
double Psen1-/2- mutant rescues this developmental defect suggesting that there 
may be a common function shared between the presenilin proteins between 
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these two distantly related species (Ludtmann et al., 2014). Finally, Dictyostelium 
development is not dependent upon Presenilin catalytic activity as mutants 
lacking catalytic activity formed normal morphology fruiting bodies when 
compared to wild-type cells (Ludtmann et al., 2014). The reasons behind these 
controversial results is not fully understood, but may be due to different 
developmental techniques or substrates used in these studies (McMains et al., 
2010, Ludtmann et al., 2014). 
The Dictyostelium presenilin proteins have also had their subcellular localisation 
examined using overexpressed Green fluorescent protein (GFP) tagged 
Presenilin proteins. The Dictyostelium Presenilin has been found to localise to 
the endoplasmic reticulum (Ludtmann et al., 2014), a similar localisation to that 
observed in mammalian cells (Smolarkiewicz et al., 2013, Fassler et al., 2011). 
This similarity in subcellular localisation further enforces the idea that these two 
presenilin proteins may behave in a similar fashion. The Presenilin proteins also 
function in calcium homeostasis in Dictyostelium as in mammalian cells and 
whole animal models(Begley et al., 1999, Keller et al., 1998, Lee et al., 2015). In 
Dictyostelium PsenB- and PsenA-/B- cells the magnitude of a cAMP-induced 
calcium response was 2-2.5 fold greater when compared to wild type cells 
(Ludtmann et al., 2014). 
Despite Dictyostelium being far removed from humans evolutionarily it is 
important to note that there are a number of similarities in terms of proteins and 
signalling pathways that are present in the organism (Eichinger et al., 2005). 
Additionally, a number of mammalian Presenilin/-secretase functions are 
conserved in Dictyostelium (Ludtmann et al., 2014, McMains et al., 2010). This 
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similarity at a signalling level as well as the advantages that the organism lends 
to laboratory research provides an alternative, non-animal, model in which to 
investigate the roles of the -secretase complex, not just proteolytically but also 
non-proteolytic roles and the roles of each individual component of the complex.  
1.7 Aims of this Study 
 This PhD thesis investigated the roles of the -secretase complex and its 
components in Dictyostelium, and conserved function with the human Presenilin 
protein. Chapter III will examine the homology between the Dictyostelium Aph-1, 
Nicastrin and Pen-2 proteins with their human orthologues and investigate the 
localisation of overexpressed GFP-tagged Aph-1 and Nicastrin. Chapter IV will 
demonstrate the process of ablating Dictyostelium Aph-1 and the resultant effects 
on Dictyostelium development, growth and component localisation. Chapter V 
studies the effects of single component null mutants in Dictyostelium to determine 
whether dysfunctional processes observed are a result of single component 
ablation or a result of the -secretase complex as a whole, and determine a 
potential underlying cause. Additionally, this study investigated whether defects 
observed are due to catalytic, or non-catalytic roles for the -secretase complex, 
and whether these functions are shared with the human Presenilin proteins.  
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Chapter II 
Materials and Methods  
40 
 
2.1 Materials 
 
2.1.1 General Reagents 
Reagents purchased from Sigma Aldrich Co (Dorset, England) 
Acrylamide (30%), ammonium persulphate (APS), bacteriological agar, -
mercaptoethanol, calcium chloride, glucose, horse serum, Luria-Burtani (LB) 
broth tablets, N,N,N’,N’-tetramethyl-etheline-1,2-diamine (TEMED), potassium 
chloride, sodium chloride, sodium dodecyl sulphate (SDS), sucrose, trisma base, 
TRITC-Dextran, triton-100, Trypan Blue powder, TWEEN20. 
Reagents purchased from Bioline (London, England) 
Agarose, deoxynucleotide trisphosphates (dNTPs), 5x DNA Loading dye 
Reagents purchased from Formedium (Norfolk, England) 
HL-5 Medium without glucose, SM Agar. 
Reagents purchased from ThermoFisher Scientific (Loughborough, England) 
Glycine, tris-acetate EDTA buffer. 
Reagents purchased from VWR International (Leicestershire, England) 
Acetic acid, acetone, bromophenol blue, ethanol, glycerol, hydrochloric acid, 
methanol, potassium dihydrogen phosphate. 
Reagents purchased from Kisker Biotech (Steinfurt, Germany) 
DQgreen/Alexa 594 co-labelled 3 m silica beads. 
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2.1.2 Antibiotics 
Geneticin (Invitrogen, Groningen, Netherlands). 
Blasticidin (Apollo Scientific, Stockport, United Kingdom). 
Penicillin/Streptomycin (Loughborough, England). 
Hygromycin (ForMedium, Norfolk, England). 
Ampicillin (Sigma-Aldrich, Dorset, England). 
2.1.3 Molecular Weight Standards 
Hyperladder 1kb DNA Ladder (Bioline, London, England). 
PageRuler Plus Prestained Protein Ladder (Fermentas, Sunderland, England). 
2.1.4 Restriction Enzymes 
All restriction enzymes and buffers (ThermoScientific, Loughborough, England). 
2.1.5 Other Enzymes 
BioTaq Polymerase (Bioline, London, England). 
Q5 DNA Polymerase (New England Biolabs, Ipswich, United States). 
RNase A, DNase (Sigma-Aldrich, Dorset, England). 
2.1.6 Antibodies 
IRDye800 Goat Anti-Mouse (Licor Biotechnologies, Cambridge, England). 
Mouse -ubiquitin (New England Biolabs, Ipswich, United States). 
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Rat -GFP, Rat -RFP (Chromotek, Martinsried, Germany). 
Mouse -Calreticulin, mouse -PDI (A kind gift from Annette Muller-
Taubenberger). 
2.1.7 Kits 
DNAse treated with DNA-Free Kit (Ambion, England). 
First Strand cDNA Synthesis Kit (Fermentas, Sunderland, England). 
QIAFilter Plasmid Maxi kit, QIAQuick PCR purification kit, QIAQuick Gel 
Extraction Kit (QIAgen, West Sussex, England). 
High Pure RNA Isolation Kit (Roche, West Sussex, England). 
GeneJET Plasmid Miniprep Kit (ThermoScientific, Loughbourough, England). 
2.1.8 Escherichia coli Strains 
TOP10 chemically competent E. coli (Invitrogen, Groningen, Netherlands). 
2.1.9 Primers 
All primers were purchased from MWG Eurofins (Westway Estate, England) or 
Sigma-Aldrich (Dorset, England). 
2.1.10 Equipment 
Bio-Rad gel casting system, PowerPac 300 Power Supply, GenePulser Xcell 
Electroporator (Bio-Rad Laboratories, Hemel Hempsted, England). 
PeqLab Mini Blue gel casting system, PeqSTAR 2x thermocycler, PeqSTAR 96 
universal thermocycler (VWR International, Leicestershire, England). 
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Centrifuge (ThermoFisher Scientific, Loughbourough, England) 
Neubauer improved haemocytometer (Hawksley, Sussex, England) 
Odyssey Infrared Imaging System (Li-Core Biotechnologies, Cambridge, 
England) 
Olympus IX71 Microscope, U-RFP-T, QImaging RetegaExi Fast1394 Digital 
camera (Olympus, Southend-on-sea, England) 
GeneFlash gel documentation system (Syngene Bio Imaging) 
Leica dissection microscope (Leica, Wetzlar, Germany) 
Ultraview VoX Inverted spinning disk microscope, LS50B Spectrophotometer 
(Perkin-Elmer, Waltham, United States) 
C9100-50-EM-CCD Camera (Hammamatsu, Japan) 
2.2 Methods 
2.2.1 Dictyostelium Methods 
2.2.1.1 Cell Culture 
 Dictyostelium stocks were maintained at -80°C in Dictyostelium freezing 
medium (7% dimethyl sulfoxide (DMSO), and horse serum). Every four weeks 
frozen cells were scraped onto SM Agar plates upon which 200 L Raoultella 
planticola was plated. Colonies were allowed form at 22°C, and cells from the 
growth zone of these colonies were transferred into liquid HL5 with glucose media 
and 100 g/mL penicillin/streptomycin. Liquid plates were washed and split three 
times per week and maintained in the log phase (1-2x106 cells/mL). Cell 
concentrations were calculated using a Neubauer improved haemocytometer. 
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2.1.1.2 Immunofluorescence Microscopy 
 To visualise Dictyostelium -secretase component protein localisation, 
cells were fixed using -80°C methanol. Cell lines overexpressing GFP/RFP-
tagged -secretase components were seeded on 13mM, thickness 1, glass 
coverslips overnight to reach confluency in HL5 medium. Coverslips were dried 
on paper towels of excess media and submerged at a 40° angle from the vertical 
to limit cell shearing in -80°C methanol (Hagedorn et al., 2006). Coverslips were 
incubated in methanol on top of dry ice for 30 minutes to allow for adequate cell 
fixation and then submerged in room temperature phosphate buffered saline. 
Following fixation cells were stained using a 1:500 dilution -GFP/Red 
fluorescent protein (RFP) antibodies to visualise -secretase components, and a 
1:5 dilution -calreticulin antibody to visualise the endoplasmic reticulum. 
Additionally, 4’,6’-diamidino-2-phylindole (DAPI) was added during the final wash 
stage at a 1:1000 dilution (final concentration 1g/mL) for 5 minutes to visualise 
the nucleus. Cells were imaged on an Olympus IX71 wide-field fluorescence 
microscope and representative images were captured. 
2.1.1.3 Development Assays 
 For development assays on nitrocellulose filters 1x107 cells were 
harvested from cells grown in liquid media, washed and resuspended in 1 mL 
KK2 (16.2mM KH2PO4, 4mM K2HPO4). Cells were evenly distributed over a 
47mm black nitrocellulose filter soaked in KK2 and incubated at 22°C for 24 hours 
in a container with wet tissue paper to maintain a humid environment.  
For development assays on 1% KK2 agar plates (5 mL KK2 and 0.05g 
bacteriological agar) 5x106 cells were harvested from cells grown in liquid media, 
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washed and resuspended in 50 L KK2. Cells were spotted on 1% KK2 agar 
plates and allowed to dry and then incubated at 22°C for 24 hours in a container 
with wet tissue paper to maintain a humid environment. 
For experiments requiring acidic or basic pH, levels of KH2PO4 or K2HPO4 were 
adjusted to reach the desired pH (Table 2.1). Cells were harvested as previously, 
but were washed and resuspended in the required pH KK2 buffer before 
incubation. All cells were incubated on pH7 soaked nitrocellulose filters for 24 
hours. 
pH % K2HPO4 % KH2PO4 
5.0 7.3 92.7 
6.0 13.2 86.8 
7.0 61.5 38.5 
8.0 94.0 6.0 
9.0 94.7 5.3 
Table 2.1. Percentages of K2HPO4 and KH2PO4 to acquire required pH levels for 
development. 
2.2.1.4 Growth Curve Assay 
For proliferation assays Dictyostelium cells were harvested and diluted in 
HL5 medium at 2x104 cells/mL. Cells were distributed in 500 L aliquots in a well 
of a 24 well plates in triplicate and allowed to grow at 22°C for 7 days. Cell density 
was counted and calculated every from day 3 to day 7. Dictyostelium cells 
containing extrachromosomal plasmids were grown in the presence of 10g/mL 
hygromycin.  
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2.2.1.5 Macropinocytosis Assay 
 To measure macropinocytosis 5x107 cells were harvested from liquid 
media and diluted in 5 mL of HL5 medium at 1x107 cells (Hacker et al., 1997). 
Cells were incubated in shaking culture for 15 minutes to recover after which 100 
L of 100 g/mL TRITC-Dextran was added to the cells. 500 L of cells were 
aliquoted and extracellular TRITC-Dextran was quenched in 50 L trypan blue 
solution (0.4% w/v trypan blue in KK2) at time points 0, 15, 30, 45, 60, 90, 120 
minutes. Immediately upon quenching cells were washed two times in KK2 buffer 
and resuspended in a final volume of 1 mL KK2 and average intracellular 
fluorescence was measured at emission wavelength 577 nm (excitation 468nm) 
over 3 readings using a Perkin Elmer LS50B Spectrophotometer. 
2.2.1.6 Autophagosome Maturation 
 To analyse autophagosome formation and maturation the autophagy 
reporter GFP-Atg8 was utilised (King et al., 2011). In order to minimise vesicle 
movement in the Z-plane, and stimulate the autophagosome formation cells were 
compressed under a thin layer of 1% agarose in HL5 medium. Cells were seeded 
in a glass-bottomed microscopy dish and covered by a ~2 mm agarose slab, 
excess media was removed by capillary action using blotting paper. After 10 
minutes, cells were imaged using a 100x objective and a 488 nm excitation laser, 
4 z-plane images were taken every 2 seconds at a distance of 1 M spacing. The 
point of autophagosome completion was determined by the enlargement and 
dimming of GFP fluorescence. The time until GFP-fluorescence was 
undetectable was measured from blinded movies captured from at least three 
independent experiments. 
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2.2.1.7 Autophagosome Measurement 
 To measure the size of GFP-Atg8 tagged autophagosomes cells were 
imaged after compression under a thin layer of 1% agarose in HL5 medium using 
a 60x oil immersion objective and GFP filter. After imaging, autophagosome size 
was measured utilising the line tool in ImageJ. Measurements were taken 
manually from the widest point of the autophagosome from blinded images. 
2.2.1.8 Phagosomal Proteolysis Assay (Carried out by Dr. Jason King, University 
of Sheffield) 
 Phagosomal proteolytic activity was measured through the use of 
DQgreen/Alexa594 labelled beads (Sattler et al., 2013). 3x105 cells were seeded 
in each well of a 96 well plate, and 3 M labelled beads were subsequently added. 
Fluorescence was measured on a plate reader each minute in triplicate. 
Normalised Alexa594 fluorescence was used to normalise proteolytic activity, 
and differences in bead uptake and rates were normalised to wild-type cells to 
calculate relative activity. 
2.2.2 Molecular Biology Techniques 
2.2.2.1 Polymerase Chain Reaction 
 Amplification of DNA using polymerase chain reaction (PCR) followed the 
conditions for standard amplification reactions: 2 – 5 L DNA, 2 L 2 mM dNTPs, 
2 L 5x NH4 reaction buffer, 0.8 L MgCl2, 0.1 L BIOTAQ DNA Polymerase (5U 
L-1), 2 L 10 pmol 5’ primer, 2 L 10 pmol 3’ primer and dH2O to bring up to 20 
L reaction volume. For amplification using a proof reading enzyme the following 
conditions were used: 2 – 5 L DNA, 2 L 2mM dNTPs, 5 L 5x Q5 Reaction 
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buffer, 0.1 L Q5 DNA Polymerase, 2 L 10 pmol 5’ primer, 2 L 10 pmol 3’ 
primer, dH2O up to 25 L total reaction volume. 
The PCR reactions were carried out using the following thermocycler conditions: 
initial denature, 10 minutes at 95°C; 30 reaction cycles at 95°C for 30 seconds, 
50°C – 68°C (depending on primer annealing temperature) for 30 seconds, 
extension at 30 seconds per kilobase at 68°C; final extension for 5 minutes at 
68°C. Samples were stored at 4°C until they could be visualised by gel 
electrophoresis. 
2.2.2.2 Gel Electrophoresis 
 To visualise and separate DNA, 1% agarose gels containing ethidium 
bromide and 1x TAE buffer were used. 5x DNA loading dye was added at the 
appropriate volume to DNA samples and samples were run alongside a 1 kb DNA 
ladder to determine fragment size. Agarose gels were run in an electrophoresis 
tank for 30 – 50 minutes at 110V and visualised with a UV light using a GeneFlash 
gel documentation system. 
To purify DNA Qiagen QIAquick Gel Extraction kits or Qiagen QIAquick PCR 
Purification kits were used following the manufacturer’s guidelines. 
2.2.2.3 Transformation of Competent E. coli 
 Chemically competent E. coli cells were thawed on ice for bacterial 
transformations. ~10 L of ligated DNA was added to 50 L competent E. coli, 
cells were incubated on ice for 30 minutes before heat-shock treatment for 30 
seconds at 42 °C. Cells were then transferred to ice for 2 minutes before the 
addition of 50 L Luria-Burtani (LB) broth followed by incubation at 37°C for 1 
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hour. After incubation cells were briefly mixed by pipetting, streaked onto LB agar 
plates (containing 20 g/mL ampicillin) and incubated overnight at 37°C. 
2.2.2.4 Plasmid Preparation 
 Verification of positive E. coli transformants was carried out without the 
use of commercial plasmid preparation kits. 2mL of positive culture was spun 
down for 2 minutes at 15,000G, supernatant aspirated and resuspended in 200 
L P1 buffer (50 mM Tris-Cl pH 8.0, 10 mM EDTA, 100 g/mL RNase A). Cells 
were lysed for 5 minutes in 200 L P2 buffer (200 mM NaOH, 1%SDS (W/V)), 
and the lysis was neutralised by addition of 200 L P3 buffer (3M potassium 
acetate pH 5.5). The neutralised lysis mixture was spun down at 15,000 G for 20 
minutes and supernatant was transferred into a clean, fresh tube. DNA was 
precipitated by the addition of 420 L isopropanol (70% reaction volume) and the 
mixture was vortexed and centrifuged for 15 minutes at 15,000 G. Supernatant 
was discarded, and 1mL 70% ethanol was added to remove residual salts. The 
DNA was vortexed and then centrifuged for 5 minutes at 15,000 G, supernatant 
discarded and residual ethanol removed by incubation at 50 °C for approximately 
10 minutes. The resultant DNA was resuspended in 30 – 50 L dH2O. 
For preparations involving commercially available kits Qiagen QIAFilter Plasmid 
Maxi kits and ThermoScientific GeneJET Plasmid Miniprep Kits were used 
following the manufacturer’s guidelines. 
2.2.2.5 Restriction Digests 
 All restriction digests followed standard restriction digest conditions: 5 L 
DNA, 0.1 – 0.4 L restriction digest enzyme(s) (100 UL-1), 2 – 5 L appropriate 
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restriction digest buffer (following manufacturer’s guidelines), dH2O to 20 – 50 L 
total reaction volume. Restriction digest mixtures were incubated at 37 °C for 1 – 
2 hours to ensure complete DNA digestion.  
2.2.2.6 Construction of Knockout Vectors 
 Generation of knockout vectors utilised the following procedure. Two 
fragments of the gene of interest open reading frame were amplified using PCR. 
Primers used for PCR amplification used restriction sites corresponding to the 
cloning vector pLPBLP (Faix et al., 2004). PCR products were purified using the 
GeneJET plasmid miniprep kit and subsequently subjected to restriction enzyme 
digest alongside pLPBLP vector, BamHI and PstI for N-terminal cloning, and NcoI 
and KpnI for C-terminal cloning. Gene fragments were ligated into the pLPBLP 
vector backbone using 0.5 T4 DNA ligase (1 U L-1), 1L T4 DNA ligase buffer 
at molar ratios of 1:5 vector: insert or 1:10 vector: insert. Ligation mixtures were 
either incubated at room temperature for 2 – 4 hours, overnight at 16°C or over 
48 hours at 4°C depending on the size of the gene insert (larger sizes were 
incubated for longer times). Ligation mixtures were heat inactivated at 70°C for 
20 minutes before transformation into chemically competent E. coli cells. 
Following colony formation on LB agar plates containing ampicillin single 
bacterial colonies were picked and grown in 5mL LB media containing 20g/mL 
ampicillin before plasmid preparation. To confirm insertion of fragment DNA 
restriction digests were performed using the previously used restriction enzymes. 
Confirmation of insertion for one gene fragment was followed by repeating the 
process with the second gene fragment into the same pLPBLP vector backbone. 
Once confirmation for both N- and C-terminal fragments was successful the 
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knockout construct was prepared using the QIAfilter Plasmid Maxi kit and 
subsequently electroporated into Dictyostelium cells. 
2.2.2.7 Construction of Overexpression Vectors 
 Overexpression vectors containing N-terminal GFP (pTX-GFP) (Levi et al., 
2000), C-terminal GFP (pDM-450) (Veltman et al., 2009) or C-terminal RFP (389-
2 RFP) (Fischer et al., 2004) tags were obtained from www.dictybase.org. Full 
length target gene cDNA was amplified by PCR using primers with appropriate 
restriction sites and a proof reading DNA polymerase. Overexpression constructs 
were restriction enzyme digested alongside vector backbones followed by ligation 
into the appropriate vector. Following confirmation of DNA fragment insertion by 
restriction digest and sequence verification by DNA sequencing plasmids were 
prepared using the QIAfilter Plasmid Maxi kits. 
2.2.2.8 Transformation of Vector Constructs into Dictyostelium 
 Dictyostelium knockout and overexpression vectors were transformed into 
Dictyostelium by electroporation (Gaudet et al., 2007). Knockout cassettes were 
prepared for transformation by excision from the vector backbone using the 
restriction enzymes BamHI and KpnI. 20g of the excised knockout cassette was 
purified using isopropanol precipitation. Overexpression vectors were 
transformed as extrachromosomal vectors and unaltered.  
For electroporation, 5x106 cells were harvested and incubated on ice for 10 
minutes before centrifugation at 1500g for 3 minutes. Cells were then washed 
twice with ice cold KK2 prior to a final wash with ice cold electroporation buffer 
(4.76g HEPES, 3.73g KCl, 0.58g NaCl, 0.12g MgSO4, 0.42g NaHCO3 and 0.156g 
NaH2PO4, pH 7.0, make up to 1L with dH2O) and then resuspended in 100 L 
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electroporation buffer. The final resuspended pellet was transferred to a 0.1mm 
cuvette and pulsed in a BIO-RAD GenePulser Xcell electroporator using 1 pulse 
at 850V and 25F. Cells were incubated on ice for 10 minutes before being 
transferred into 10mL HL5 media containing 10g/mL penicillin/streptomycin. 
Knockout transformants were transferred to each well of a 96 well plate, whilst 
overexpression transformants were transferred to a 10cm tissue culture dish. 
After 24 hours 100L of 20g/mL blasticidin in HL5 media was transferred to each 
well of the 96 well plate for knockout transformants, for overexpression 
transformants 10L of 10g/mL geneticin or hygromycin was added to the tissue 
culture plate. 
2.2.2.9 Extraction of DNA from Potential Transformants 
 In order to confirm successful transformation of the knockout cassette 
transformants growing in the presence of blasticidin after transformation were 
harvested once they reached confluence. Cells were centrifuged for 3 minutes at 
1000g and resuspended in 48L lysis buffer (50mM KCl, 10mM Tris pH 8.3, 2.5M 
MgCl2, 0.45% Nonidet P40, 0.45% TWEEN 20) and 2L Proteinase K (822 U mL-
1) and incubated for 5 minutes. Proteinase K was inactivated at 95°C for 1 minute 
following incubation, and the resultant DNA was used in PCR reactions to screen 
for correct homologous recombinant knockouts. 
2.2.2.9 Screening for Homologous Recombinants 
 Primers were designed to determine whether Dictyostelium cells 
transformed with the knockout construct underwent target gene ablation with a 
correctly incorporated knockout cassette. Genomic DNA was extracted from cells 
and used in PCR analysis based on 3 different primer combinations to screen for 
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the knockout cassette. Genomic control primers were designed to amplify DNA 
from 3’ and 5’ regions flanking the fragments used in the knockout cassette, these 
would amplify non-deleted regions of the gene. Vector control primers were 
designed to amplify DNA from within the DNA fragments used in the vector 
construction and in the blasticidin resistance gene, these would confirm the 
transformation of the knockout cassette. Knockout diagnostic primers used a 
flanking primer from the genomic control reaction and the blasticidin resistance 
cassette primer from the vector control reaction to determine whether the 
cassette was inserted into the correct region of the Dictyostelium genome. Primer 
combinations were designed to screen both the 3’ and 5’ fragments of the 
knockout cassette. 
2.2.2.11 Sub Cloning of Correct Transformants 
 To allow for isogenic cell line selection of correct knockout transformants 
cells were plated onto SM agar plates with 200L Raoultella planticola. After 
incubation at 22°C single colonies were selected, genomic DNA was extracted 
and re-screened with the PCR primers previously described (Section 2.2.2.10). 
2.2.2.12 RNA Extraction and Reverse Transcriptase PCR 
 To confirm gene ablation 1x107 Dictyostelium cells were harvested. These 
cells were washed and resuspended in KK2 before the RNA was extracted using 
a High Pure RNA Isolation Kit (Roche) according to manufacturer instructions.  
Following RNA extraction cDNA was synthesised to allow for RT PCR. Extracted 
RNA was used at 1-4g to synthesise cDNA using a First Strand cDNA synthesis 
kit following the manufacturer’s instructions. Following this, 2L cDNA was used 
in PCR amplification. Primers used in the PCR were designed to flank the 
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blasticidin resistance cassette in knockout cell lines giving a small ~400 base pair 
product in wild-type cells and a ~1800 base pair, or no product, for knockout cells.  
2.2.3 Proteomics 
2.2.3.1 Western Blot Analysis 
 To analyse high molecular weight ubiquitinated protein content 5x106 cells 
were harvested and resuspended and incubated for 10 minutes in 100 L of PBS 
(10x – 14.4g Na2HPO4, 80g NaCl, 2g KCl, 2.4g KH2PO4 made up to 1 L with 
dH2O, pH 7.4) supplemented with 0.1% NP40 and 1% TritonX-100 and protease 
inhibitors (Calvo-Garrido and Escalante, 2010). Cells were then passed through 
a 30-gauge needle four times to allow for complete cell disruption. Extracts were 
centrifuged at 17500g for 5 minutes and the supernatant was decanted and mixed 
with 20L 5x SDS loading buffer (0.8mL 2M Tris pH 6.8, 3mL 80% glycerol, 5mL 
10% SDS, 1.25 mL -mercaptoethanol, water to 10mL, bromophenol blue) before 
boiling at 95°C for 10 minutes. Protein samples were loaded into the stacking gel 
(stacking gel – 425 L 30% acrylamide solution, 157.5 L Tris pH 6.8, 1.875 mL 
dH2O, 25L 10% SDS, 25 L 10% ammonium persulphate, 7.5 L TEMED. 
Resolving gel – 2.215 mL 30% acrylamide, 0.95 mL Tris pH 8.8, 1.825 mL dH2O, 
100L 10%SDS, 50 L 10% ammonium persulphate, 5 L TEMED) alongside a 
molecular marker, PageRuler Plus Prestained Protein Ladder. The gel was run 
at 200 V for 35 minutes in 1x running buffer (10x – 30g Trisma base, 144g glycine, 
100 mL 10% SDS, made up to 1L with dH2O). The separated protein was blotted 
onto a PVDF membrane activated in methanol. All materials for blotting, blotting 
paper, sponges and activated membrane were soaked in ice cold transfer buffer 
containing 10% ETB buffer (10x – 75g Trisma base, 360g glycine, 25 mL 10% 
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SDS) with 10% methanol. The transfer blot was added to a tank containing ice 
cold transfer buffer placed inside a filled ice box and run at 200 mA for 2 hours. 
Once blotting was completed the PVDF membrane was incubated using 5mL 5% 
skimmed milk in PBST (1x PBS + 1% TWEEN 20) for 1 hour. The -ubiquitin 
antibody was prepared at 1:1000 dilution, and -PDI as a loading control at 1:10 
in skimmed milk in PBST and incubated at 4°C overnight. Primary antibody was 
then washed away with 1x PBS followed by 3 x 10 minute washes in PBST. The 
appropriate secondary antibodies were then added at a 1:10,000 dilution in 
skimmed milk + PBST before imaging on an Odyssey Infrared Imaging System. 
Following imaging western blots were analysed using the LiCor Image Studio 
software. Total ubiquitinated protein content was calculated against the 
appropriate loading control, and normalised against wild-type.  
2.2.4 Bioinformatic Analysis 
In order to determine evolutionary conservation of the target proteins Aph-1, 
Pen-2 and Ncstn, phylogenetic trees were generated using the program Mega 
5.1 (Kumar et al., 2008). Briefly, amino acid sequences were gathered from 
Uniprot for proteins of interest from several different organisms spanning the 
animal and plant clades (The UniProt, 2017). These sequences were then 
aligned using ClustalW alignment (Goujon et al., 2010). After alignment a 
Neighbour-Joining tree was generated using the Bootstrap method and 500 
Bootstrap replications, the substitution model used was the Poisson model. 
Outgroups were chosen by selecting distantly related proteins. 
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2.3 Statistical Analyses 
To determine statistical significance tests varied depending upon the 
criteria. First, data was determined to be normally distributed as shown by the 
D’agostino & Pearson normality test. For experiments comparing mean values 
from several data sets (growth assays, macropinocytosis assay, GFP-Atg8 
measurement and quenching assays) a two-way ANOVA was used with the 
Bonferroni post-hoc test to compare multiple data sets to each other. For data 
comparing values to a normalised value (ubiqutinated protein western blot) a 
one sample T-test was utilised. In all graphical representations of data error 
bars shown are standard error of the mean. * denotes p<0.05, ** denotes 
p<0.01, *** denotes p<0.0001. 
2.4 Software 
Microscopy analysis for Atg8 quenching was carried out using Fiji 
(Schindelin et al., 2012). GraphPad was used for statistical analysis (GraphPad 
Software Inc, California, United States). Western blot analysis used Image Studio 
Lite (LiCor Biotechnologies, Cambridge, United Kingdom). Mega 5.1 software 
was used for phylogenetic analysis (Kumar et al., 2008). 
2.5 Websites 
Dictyostelium gene and protein information 
www.dictybase.org 
Dictyostelium gene expression information 
www.dictyexpress.biolab.sl 
Basic Local Alignment Search Tool (BLAST) Analysis 
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www.dictybase.org/tools/blast 
www.ncbi.nlm.nih.gov/BLAST 
Protein sequence alignment 
www.ebi.ac.uk/tools/msa/clustalo 
Protein domain prediction 
http://www.cbs.dtu.dk/services/TMHMM/ 
Protein information 
www.uniprot.org 
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Chapter III 
The Dictyostelium -secretase Complex 
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3.1 Introduction 
 The -secretase complex has been studied in Dictyostelium to advance 
our knowledge of its cellular and developmental function showing roles for the 
complex in development, exogenous substrate cleavage, phagocytosis and 
calcium homeostasis (McMains et al., 2010, Ludtmann et al., 2014). These 
studies, however, have not included detailed research into the homology between 
Dictyostelium and human components apart from Presenilin (Ludtmann et al., 
2014). In order to better understand the role of the other components of the 
complex it is necessary to investigate these components, and compare the 
Dictyostelium components with their human orthologues 
Dictyostelium has been successfully used as a model organism to investigate the 
roles and functions of Presenilin (McMains et al., 2010, Ludtmann et al., 2014). 
These studies have found roles for this protein in Dictyostelium development, 
intracellular calcium signalling, phagocytosis and an evolutionary conservation of 
catalytic activity (McMains et al., 2010, Ludtmann et al., 2014). However, with 
regards to the remaining components of this protein complex there has been 
some conflicting evidence. One study, for example, shows a role for presenilin, 
Aph-1 and Nicastrin in Dictyostelium development (McMains et al., 2010), whilst 
another shows that Nicastrin null cell lines develop comparable to wild-type cells 
(Ludtmann et al., 2014). Studies in Dictyostelium have also shown that the 
presenilin proteins localise to the endoplasmic reticulum (Ludtmann et al., 2014), 
a localisation also found in mammalian model organisms used to investigate this 
protein, and the -secretase complex (Xia et al., 1998, Smolarkiewicz et al., 
2013). 
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In this chapter, we will compare the human and Dictyostelium -secretase 
components Aph-1, Nicastrin and Pen-2 against their human counterparts. Using 
bioinformatic tools (Altschul et al., 1990, Pasquier et al., 1999) we will investigate 
similarities in size, as well as conservation of important domains and motifs in 
these proteins. Additionally, we will investigate the localisation of these 
components and compare their localisation in Dictyostelium with mammalian 
model organisms.  
3.2 Dictyostelium and human Aph-1 
In order to determine whether Dictyostelium is a viable model organism to 
investigate the function of Aph-1 a number of bioinformatic analyses were carried 
out. The aim of these was to use a bioinformatics approach to improve our 
understanding of the Dictyostelium Aph-1 protein and to establish similarities to 
the orthologous mammalian protein. 
Upon bioinformatic analysis of Aph-1 between Dictyostelium and humans several 
similarities are observed. The Aph-1 orthologues are closely related in size with 
the Dictyostelium Aph-1 containing 328 amino acids and the human Aph-1A and 
Aph-1B containing 265 and 257 amino acids respectively (Figure 3.1A). 
Additionally, these orthologues possess 7 conserved transmembrane domains of 
similar length and position, containing similar hydrophobic amino acids and by 
using the TMHMM Server (Krogh et al., 2001), (Figure 3.1 A, D), and a conserved 
GxxxGxxxG motif in transmembrane domain 4 (Figure 3.1 A, C) (Appendix 1). 
The Dictyostelium Aph-1 when visualised on a phylogenetic tree is more similar 
to the animal clade than plant Aph-1 proteins (Figure 3.1B).  
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 Figure 3.1 Bioinformatic 
analysis of Dictyostelium 
Aph-1. A) Schematic 
representations of 
Dictyostelium Aph-1, and 
human Aph-1A and Aph-
1B. The relative lengths of 
Aph-1 is similar between 
Dictyostelium and the two 
human Aph-1 proteins, as 
well as location, size and 
number of transmembrane 
domains (Blue). 
Additionally, there is a 
conserved GxxxGxxxG 
motif across all three 
proteins in transmembrane 
domain 4 (Red). B) 
Phylogenetic analysis 
between human, mouse, 
Xenopus, Drosophila, 
Dictyostelium, C. elegans, 
Arabidopsis, 
Physcomitrella, R. 
communis and Oryza Aph-1 
proteins. The Dictyostelium 
protein clusters more 
closely to the animal 
proteins than the plant or C. 
elegans proteins.C) 
Alignment of the conserved 
GxxxGxxxG motif across a 
number of species including 
Dictyostelium, human, and 
mouse. Blue boxes indicate 
conserved glycine residues 
in the GxxxGxxxG motif, 
red boxes indicate 
deviations from conserved 
glycine. D) A table 
demonstrating the identity, 
and similarity of each of the 
7 transmembrane domains 
across Dictyostelium and 
human proteins including 
the average identity and 
similarity. 
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An important domain within the Aph-1 protein is the GxxxGxxxG motif located in 
transmembrane domain 4 (Lee et al., 2004b). This motif is required for Aph-1 to 
integrate into, and potentially stabilise, the -secretase complex  (Lee et al., 
2004b). This motif is highly conserved between human and mouse Aph-1 
isoforms, and is also present in Dictyostelium. However, in the plant model 
organisms A. thaliana and P. patens the motif is reduced to GxxxG (Figure 3.1 
C).   
3.3 Dictyostelium and human Nicastrin 
Nicastrin was analysed in order to determine similarity between the human 
and Dictyostelium proteins. The aim of this was to compare domains and motifs 
of the proteins, and to compare the size, placement and identity with the human 
and rodent proteins. 
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Figure 3.2 Bioinformatic analysis of Dictyostelium Nicastrin. A) Phylogenetic analysis 
between human, rat, mouse, Xenopus, Drosophila, C. quinquefasciatus, Dictyostelium, 
Arabidopsis, Physcomitrella, V. vinifera, A. tauschii, and T. urarfu Nicastrin proteins. The 
Dictyostelium protein clusters more closely to the animal proteins than the plant proteins. B) 
Schematic representations of Dictyostelium Nicastrin, and human Nicastrin. The relative lengths 
of the protein is similar between Dictyostelium and the human protein, as well as location, size 
and number of transmembrane domains (Blue). Additionally, there is a conserved DYIGS motif 
across both proteins in the extracellular domain 4 (Green). C) Alignment of the conserved 
DYIGS motif across a number of species including Dictyostelium, human, mouse, A. thaliana 
and P. patens. Blue boxes indicate conserved amino acids across species. 
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In Dictyostelium and other model organisms there is only one copy of the 
Nicastrin protein (Smolarkiewicz et al., 2013, De Strooper, 2003, Ludtmann et al., 
2014). Through phylogenetic analysis the Dictyostelium Nicastrin protein clusters 
more towards the mammalian, and animal clade than the plant clade (Figure 
3.2A). Additionally, the overall size between the proteins is quite similar, the 
Dictyostelium protein measures 659 amino acids, whilst the human protein 
measures 709 amino acids. Both orthologues share one transmembrane domain, 
and a common DYIGS motif (Figure 3.2B). The DYIGS motif in Nicastrin is 
required for integration into, and stability or substrate recognition in the -
secretase complex (Lim et al., 2015) (Appendix 2).  
3.4 Dictyostelium and human Pen-2 
 Pen-2 was analysed to determine homology between the human and 
Dictyostelium proteins. Orthologues were compared to determine similarity in 
size, and conservation of important motifs and domains within the protein.  
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Figure 3.3 Bioinformatic analysis of Pen-2. A) Schematic representations of Dictyostelium 
and human Pen-2 comparing Dictyostelium and human Pen-2. The overall length between 
Dictyostelium and human Pen-2 is highly similar, with only four amino acid difference between 
orthologues. Transmembrane domains (blue) are localised to similar positions within the two 
proteins and are of similar size. Additionally, the C-terminal domains share a conserved DYLSF 
(brown) motif. B) Phylogenetic analysis of human, mouse, rat, zebrafish, frog, fruit fly, C. 
elegans, Dictyostelium, P. patens, G. aurea, Arabidopsis, and C. clementina Pen-2 proteins 
show that the Dictyostelium protein clusters more closely to the animal clade than the plant 
proteins. C) Alignment of the Pen-2 C-terminal domain across species including human, mouse, 
Dictyostelium, P. patens and Arabidopsis. The Pen-2 C-terminus is highly conserved across a 
number of species. Blue boxes indicate identical amino acids. Red box denotes a different 
amino acid in a conserved region. 
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The Dictyostelium and human Pen-2 proteins share a number of similarities in 
their structure. The orthologous Pen-2 proteins show similar size with the 
Dictyostelium protein containing 97 amino acids, and the human protein 
containing 101 amino acids. Additionally, both proteins contain similar sized and 
positioned transmembrane domains with a highly conserved C-terminal domain 
and DYSLF motif (Figure 3.3 A). Phylogenetic analsysis demonstrates that the 
Dictyostelium protein more closely clusters to the animal and mammalian clade 
than the plant clade suggesting evolutionary conservation for this protein 
between animals and Dictyostelium (Figure 3.3 B). Finally, the C-terminus of Pen-
2 is important for the protein to function and integrate into the -secretase 
complex (Mao et al., 2012). Here we show that the Dictyostelium Pen-2 C-
terminus is highly conserved between Dictyostelium, humans, mouse and other 
organisms (Figure 3.3 C) including conserved amino acids within the important 
DYLSF motif (Mao et al., 2012) (Figure 3.3 A, C) (Appendix 3).  
3.5 Localisation of the -secretase complex components 
In mammalian model organisms the -secretase complex localises to the 
endoplasmic reticulum (Area-Gomez et al., 2009). The complex forms 
sequentially, first Aph-1 and Nicastrin form a holocomplex, this complex is then 
joined by PsenA/B, and finally Pen-2 (Mao et al., 2012). Once fully formed the 
complex is shuttled between the plasma membrane, Golgi apparatus and ER. 
The vast majority (95%) of the complex is localised to the ER, whilst the remaining 
portion (5%) is localised to the Golgi Apparatus and plasma membrane 
(Smolarkiewicz et al., 2013). 
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In Dictyostelium, Presenilin has been found to localise to the endoplasmic 
reticulum (Ludtmann et al., 2014). This localisation is unaltered when catalytic 
activity is ablated, and is also preserved when the human Presenilin 1 protein is 
expressed in this organism (Ludtmann et al., 2014). The localisation of other 
components in Dictyostelium however is not yet known, as other studies have not 
yet investigated this. 
3.5.1 Generation of overexpression constructs 
 To allow visualisation of -secretase complex components in 
Dictyostelium, overexpression constructs were generated for each component 
(Chapter II). Amplified genes were cloned into GFP-tagged vectors and 
expressed in Dictyostelium (Levi et al., 2000, Fischer et al., 2004) before 
visualisation and analysis of colocalisation.   
3.5.1.1 Generation of an Aph-1 overexpression construct 
 To determine subcellular localisation of Aph-1 an extrachromosomal 
overexpression construct was generated. The overexpression construct was 
generated through amplification of the Aph-1 open reading frame using a cDNA 
template. After amplification the product was cloned into the pTX-GFP expression 
vector (Levi et al., 2000) (Figure 3.4 A) and integration was confirmed by 
restriction digest (Figure 3.4 B). Vectors were sequenced to ensure they were 
mutation free and subsequently cloned into Dictyostelium. Transformants 
growing in the presence of neomycin were allowed to grow to confluency before 
visualisation to ensure fluorescent protein production. Localisation of GFP-Aph-
1 appeared to be membrane bound and similar to the endoplasmic reticulum 
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localisation found in Presenilin studies in Dictyostelium (Ludtmann et al., 2014) 
(Figure 3.4 C). 
 
Figure 3.4 Generation of an Aph-1 overexpression construct. A) The Aph-1 open reading 
frame was amplified from cDNA using 5’ and 3’ primers containing cutsites for BamHI and XbaI. 
The generated product was cloned into the pTX-GFP containing an N-terminal GFP-tag. B) To 
confirm integration of the Aph-1 ORF restriction digest of the constructed vector was carried out 
using BamHI and XbaI. C) To confirm tagged protein production cells were visualised using a 
GFP-filter and 60x micoroscope objective. Scale bar = 10m 
3.5.1.2 Generation of a Nicastrin overexpression construct 
 To allow visualisation of Nicastrin in Dictyostelium an RFP-tagged 
overexpression construct was generated. The construct was generated by 
amplifying the Nicastrin open reading frame from cDNA before subsequent 
cloning into the C-terminal RFP vector 389-2 (a kind gift from Annette Muller-
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Taubenberger) (Figure 3.5 A, B) and sequencing to ensure the construct was 
mutation free. After succesful cloning and transformation into Dictyostelium cells 
were visualised to confirm RFP tagged protein production. Visualisation of RFP-
Nicastrin demonstrated membrane bound staining, potentially localising to the 
endoplasmic reticulum (Figure 3.5 C). 
 
Figure 3.5 Generation of a Nicastrin overexpression construct. A) The Nicastrin open 
reading frame was amplified using 5’ and 3’ primers containing cutsites for BglII and SpeI. The 
generated product was cloned into the C-terminal RFP vector 389-2. B) Restriction digest of the 
constructed vector using BglII and SpeI showed successful integration of the Nicastrin open 
reading frame into the target vector. C) Visualisation of Ncstn-RFP cells showed the presence 
of fluorescently tagged protein. Scale bar = 10m. 
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3.5.1.3 Generation of a Pen-2 overexpression construct 
An RFP-Pen-2 construct was generated to allow visualisation of Pen-2 in 
Dictyostelium. The construct was generated by amplification of the Pen-2 open 
reading frame from cDNA before cloning into an N-terminal RFP vector, pTX-RFP 
(Figure 3.6 A) (Fischer et al., 2004). Following confirmation of cloning through 
restriction digest and sequencing the construct was transformed into 
Dictyostelium cells (Figure 3.6 B). Visualisation of RFP-Pen-2 transformants 
however did not show any specific protein localisation and the staining we 
observed was likely to be background staining (Figure 3.6 C). Subsequent 
western blot analysis of RFP-Pen-2 cells showed no fusion RFP-Pen-2 protein.  
71 
 
 
Figure 3.6 Generation of an RFP-Pen-2 construct. A) A Pen-2 overexpression construct was 
generated through the amplification of the Pen-2 open reading frame from a cDNA template 
with primers containing cutsites for the restriction enzymes BamHI and XbaI. Following 
amplification the product was ligated into the N-terminal RFP vector pTX-RFP. B) Restriction 
digest of the constructed vector with the enzymes BamHI and XbaI showed succesful cloning of 
the Pen-2 gene into the target vector. C) Visualisation of RFP-Pen-2 in cells showed no specific 
localisation of RFP-Pen-2 in wild-type Dictyostelium cells. D) Western blot analysis of RFP-Pen-
2 cells for the presence of a fusion protein showed no RFP-tagged protein. Scale bar = 10m. 
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3.5.2 Localisation of the -secretase complex components in Dictyostelium 
 In mammalian cells the -secretase complex components have been 
shown to localise to the endoplasmic reticulum (Xia et al., 1998, Gu et al., 2003, 
Niimura et al., 2005). In Dictyostelium, Presenilin has also been found to localise 
to the ER (Ludtmann et al., 2014), however the localisation of the other cellular 
components is unknown.  
In order to confirm whether the localisation observed upon overexpression of 
Aph-1 or Nicastrin (Figure 3.4 C, 3.5 C) is to the endoplasmic reticulum we carried 
out colocalisation studies using the endoplasmic reticulum protein calnexin 
(Muller-Taubenberger et al., 2001). Upon imaging and digitally overlaying cells 
overexpressing GFP-Aph-1 stained with -GFP and -calnexin antibodies we 
observed co-localisation between Aph-1 and Calnexin (Figure 3.7 A). However, 
due to the use of methanol in fixation the endoplasmic reticulum structure was 
not preserved. We sought to maintain the endoplasmic reticulum structure in 
these cells and next attempted to visualise live cells co-expressing GFP-Aph-1 
and Nicastrin-RFP under a thin sheet of 1% agarose (Figure 3.7 B). In these 
experiments, co-localisation could once again be observed, and the endoplasmic 
reticulum was able to maintain its structure, however as the cells were still alive 
during the imaging process their movement altered the position of labelled 
structures.  
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Figure 3.7 Localisation of Aph-1 and Ncstn in Dictyostelium. A) Immunofluorescence 
imaging of GFP-Aph-1 overexpressing cells stained with -GFP and -Calnexin antibodies. 
Cells show co-localisation between Aph-1 and Calnexin, however endoplasmic reticulum 
structure is disrupted due to fixation in methanol. B) Live cell imaging of cells overxpressing 
GFP-Aph-1 and Nicastrin-RFP. Co-localisation can be observed between Aph-1 and Nicastrin in 
these cells, however, as the cells were still alive during the imaging process the position of the 
internal structures was altered during imaging. Scale bar = 10m. 
To maintain the endoplasmic reticulum structure and ensure cells could not move 
during the imaging process we carried out immunofluorescence using -80°C 
methanol for fixation (Hagedorn et al., 2006). In these experiments we imaged 
cells overexpressing GFP-Aph-1, Nicastrin-RFP, and PsenB-GFP (Ludtmann et 
al., 2014). The antibodies used were  -GFP to stain GFP-Aph-1 and PsenB-
GFP,-RFP to stain Nicastrin and -calreticulin to stain the endoplasmic 
reticulum (Muller-Taubenberger et al., 2001). These experiments confirmed 
PsenB localises to the endoplasmic reticulum (Ludtmann et al., 2014), and 
further, showed for the first time that Aph-1 and Nicastrin also localise to the ER 
in Dictyostelium (Figure 3.8) indicating that the entire -secretase complex may 
localise to the ER in Dictyostelium. However, it is worth noting that mislocalisation 
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can be observed upon overexpression and these localisations must be confirmed 
using alternative methods. 
 
Figure 3.8 Localisation of -secretase components, PsenB, Aph-1 and Ncstn in 
Dictyostelium. In wild-type cells fixed in methanol, GFP tagged fusion proteins of PsenB, Aph-
1, and Nicastrin co-localise with the endoplasmic reticulum marker calreticulin. Scale bar = 
10m. 
3.6 Discussion 
 Understanding whether the Dictyostelium -secretase complex 
components share homology with their mammalian counterparts is important to 
determine whether the organism can be used to investigate these proteins. Whilst 
Dictyostelium has been used to investigate the -secretase complex (McMains et 
al., 2010, Ludtmann et al., 2014) there has been limited research done on the 
homology of these components between Dictyostelium and humans. Additionally, 
the localisation of the -secretase complex in Dictyostelium remains 
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uninvestigated, with only the Presenilin localisation known (Ludtmann et al., 
2014).  
In this chapter we analysed the homology between the Dictyostelium -
secretase components Aph-1, Nicastrin and Pen-2 to their human counterparts 
to compare the conservation of protein size, structure and motifs and domains. 
We show here, that the Dictyostelium Aph-1 protein shares the motif 
GxxxGxxxG with mammalian and animal model organisms (Figure 3.1 C). This 
GxxxGxxxG motif has been suggested to be important for Aph-1 function within 
the -secretase complex as ablation of one of the glycine residues in C. elegans 
results in a Notch null phenotype, and non-integration of Aph-1 into the protein 
complex (Lee et al., 2004b). Further, whilst humans possess two Aph-1 proteins 
Aph-1 A and B (Lee et al., 2002), and mice possess three Aph-1 proteins Aph-1 
A, B and C (Ma et al., 2005), Dictyostelium only possesses one Aph-1 isoform. 
The Aph-1 present in Dictyostelium shares higher homology to the human Aph-
1 A, the primary Aph-1 protein in humans and mice during development (Ma et 
al., 2005), suggesting that this Aph-1 protein is likely to be the original Aph-1 
isoform and the most evolutionarily conserved with the Aph-1 B isoform 
appearing later in the evolutionary timeline. The Dictyostelium and mammalian 
Nicastrin proteins share the conserved motif DYIGS (Figure 3.2 C). Whilst 
Dictyostelium does not have a completely conserved DYIGS motif, it does 
contain the conserved glycine residue shown to be important for the integration 
of Nicastrin into the -secretase complex, substrate recognition and subsequent 
processing (Lim et al., 2015, Dries et al., 2009), however this is controversial. 
Finally, the Dictyostelium Pen-2 protein contains a highly conserved C-terminal 
domain shown to be responsible for the stabilisation of the -secretase complex 
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(Prokop et al., 2005). The results shown, and data discussed here suggest that 
Dictyostelium can be used as a model organism to investigate the basic 
function of the -secretase complex due to the conservation of important motifs, 
domains, size and structure. Although phylogenetic trees are useful tools for 
evolutionary analysis of target genes or proteins several limitations do exist. 
These limitations include difficulties when genes may be altered through genetic 
recombination (Arenas and Posada, 2010) or horizontal gene transfer (Woese, 
2002) giving anomalous branch positioning and therefore incorrect evolutionary 
analysis by showing unrelated organisms as descendents. Additionally, issues 
may arise due to long branch attraction artefacts where organisms undergoing 
rapid evolutionary changes appear related solely due to due the large amount of 
change and not because they are related (Philippe et al., 2005). With these 
limitations in mind and the effects they may pose to the formation, and 
positioning of the phylogenetic tree it is important to view these as a literal 
scientific hypothesis upon which to base further research.  
In mammals the localisation of the -secretase complex has been shown at the 
endoplasmic reticulum, Golgi apparatus and plasma membrane (Xia et al., 1998, 
Area-Gomez et al., 2009). However, in Dictyostelium only the localisation of 
Presenilin has been investigated and found at the endoplasmic reticulum 
(Ludtmann et al., 2014). In this chapter, we described for the first time to our 
knowledge the localisation of Aph-1 and Nicastrin to the endoplasmic reticulum 
in Dictyostelium, sharing localisation with Dictyostelium Presenilin and 
comparable localisation to the mammalian protein complex (Xia et al., 1998). It is 
important to note however that this endoplasmic reticulum localisation has been 
observed through the use of overexpression constructs. Overexpression of these 
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components may result in abnormal localisation as found in other studies 
(Gahlmann and Moerner, 2014), and therefore future studies may wish to use 
alternative methods to visualise protein localisation such as fluorescent tagged 
knock in proteins, or custom generated antibodies for immunofluorescence. 
Additionally, this chapter has detailed the efforts to generate a Pen-2 
overexpression construct, however, this construct failed to produce full length 
RFP-Pen-2 fusion protein as observed through the absence of a fluorescent 
signal through microscopy and an absence of RFP-Pen-2 in western blot 
analysis. This was not pursued further due to time constraints, however causes 
behind the failure of expression may be due to disruption of signal/targetting 
peptides. C-terminal vectors may be pursued as these are less likely to interfere 
with protein localisation. 
This chapter set out to determine whether Dictyostelium could provide a viable 
model organism for research of the -secretase complex. We have shown here, 
that the Dictyostelium -secretase complex components share important protein 
structure, motifs and domains with their human counterparts (Lee et al., 2004b, 
Lim et al., 2015, Prokop et al., 2005). We additionally demonstrate that the 
Dictyostelium Aph-1 and Nicastrin proteins localise to the endoplasmic reticulum 
with Dictyostelium Presenilin B (Ludtmann et al., 2014), sharing subcellular 
localisation with their human counterparts (Xia et al., 1998). These results 
suggest that Dictyostelium can be used as a model organism to investigate the 
function of the -secretase complex. 
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Chapter IV 
Genetic manipulation of -secretase 
components and characterisation of 
mutants 
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4.1 Introduction 
 As the -secretase complex is important for understanding both 
development and disease in mammalian model organisms, it is important to 
develop a thorough understanding of its function. However, in mammalian 
models, ablation of either single or multiple components of the complex is highly 
problematic due to embryonic lethality (De Strooper et al., 1999). Therefore, novel 
approaches are necessary to develop understanding of this complex. This 
chapter describes the genetic manipulation of the aph-1 and pen-2 genes in 
Dictyostelium. It further describes the effects of aph-1 ablation on Dictyostelium 
development and compares these results to those previously published about 
ncstn and psenA/B ablation (Ludtmann et al., 2014, McMains et al., 2010). 
Finally, this chapter investigates the role of -secretase components on 
Dictyostelium growth in liquid media, and the localisation of these components in 
knock-out backgrounds for aph-1 and psenA/B. 
Dictyostelium development is a common method utilised to determine the effects 
of gene ablation on the organism (Ludtmann et al., 2014, McMains et al., 2010, 
Otto et al., 2016). Previous research has determined that the presenilin protein is 
required for this process to function normally in a manner not dependent upon 
the catalytic activity of the protein (McMains et al., 2010, Ludtmann et al., 2014). 
The roles for the other components however is controversial, Ncstn has been 
found to be both required, and dispensable for development over a 24 hour period 
(Ludtmann et al., 2014, McMains et al., 2010), whilst Aph-1 has been found to be 
necessary (McMains et al., 2010).  
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Phagocytosis and macropinocytosis are both important processes by which 
Dictyostelium ingest extracellular nutrients for processes such as growth (Chubb 
et al., 2000, Muller-Taubenberger et al., 2001, Bloomfield et al., 2015). Presenilin 
has been shown to function in Dictyostelium phagocytosis as null mutants are 
unable to ingest yeast effectively when compared to wild-type cells, and therefore 
grow at a slower rate (McMains et al., 2010). This function is reliant upon catalytic 
activity of this protein, but is not reliant upon a fully formed -secretase complex 
as Aph-1 and Ncstn null cells are able to phagocytose normally (McMains et al., 
2010). The effects of ablation of these components on growth in liquid media has 
not yet been investigated. 
As the formation of the -secretase complex is sequential (Smolarkiewicz et al., 
2013), we also set out to determine whether the localisation of these complex 
components are altered in null background lines. Thus far, to our knowledge, this 
has not been investigate in Dictyostelium or in mammalian models, however, it 
has been shown that presenilin localises to similar intracellular compartments as 
the mammalian orthologue in wild-type and PsenA/B null backgrounds 
(Ludtmann et al., 2014).  
This chapter will report on successful deletion of part of the Dictyostelium aph-1 
to allow for analysis of the effects of aph-1 ablation on Dictyostelium 
development, and will detail the efforts to delete part of the Dictyostelium pen-2 
gene. Additionally, this chapter will investigate the effects of -secretase ablation, 
through ablation of aph-1, ncstn, and psenA/B on Dictyostelium growth, and -
secretase component localisation in the absence of Aph-1 and PsenA/B.  
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Figure 4.1 Genetic modification through homologous recombination. A gene targeting 
cassette is constructed with two arms of homology identical to the target gene flanking a 
resistance cassette. This is then transformed into Dictyostelium where homologous 
recombination occurs through a crossover of similar, or identical, nucleotides between two 
strands of DNA. The resultant modified gene now contains the desired substitution/deletion 
mutation.  
 
4.2 Creating an aph-1 knock-out mutant 
 The Dictyostelium aph-1 gene was ablated through the homologous 
recombination of a knock-out cassette (Chapter 2.2.2.8) (Faix et al., 2004). The 
homologous recombination cassette was generated through the amplification of 
two arms of homology by PCR, a 5’ fragment, and a 3’ fragment matching the 
target gene, resulting in the deletion of 210 base pairs from the target gene 
(Figure 4.2 A, B). These fragments flank a blasticidin resistance marker that 
allows for selection of positive transformants (Figure 4.2 B). To confirm that the 
correct sequences were cloned into a knock-out vector (pLPBLP) (Faix et al., 
2004)  restriction digests were used to detect the presence of the 5’ and 3’ aph-
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1 fragments and the entire homologous recombination cassette (Figure 4.2 C). 
The targeting cassette was also sequenced for further confirmation. Wild-type 
Dictyostelium Ax2 cells were transformed with the knock-out cassette digested 
with BamHI and KpnI, and plated in a 96-well plate containing blasiticidin 
(10g/mL) to allow for selection of positive transformants.  
Figure 4.2 Generation of an aph-1 knockout cassette. A) Fragments of aph-1 genomic DNA 
were amplified by PCR using 5’ and 3’ primers containing cutsites for BamHI, PstI, NcoI, and 
KpnI. B) N-terminal (5’) (550bp) and C-terminal (3’) (469bp) fragments were cloned into the 
pLPBLP vector flanking a blasticidin resistance cassette. C) To confirm successful integration of 
5’ and 3’ fragments, a series of restriction digests were used. Double digests of BamHI and PstI 
generated the correct 5’ fragment, and NcoI and KpnI generated the correct 3’ fragment, 
additionally a BamHI and KpnI digest generated a linearised homologous recombination 
cassette (2855bp) which would be used in electroporation. Single digests using BamHI, PstI, 
NcoI, and KpnI were used as controls to ensure adequate restriction digestion.   
In order to identify strains that underwent homologous recombination of the 
knock-out cassette positive transformants growing in the presence of blasticidin 
were screened by PCR (Figure 4.3). In these experiments, three primer 
combinations were used genomic DNA (GC) control, vector DNA (VC) control 
and positive homologous recombination knock-outs (KO). The GC reaction 
primers were designed so that one primer annealed in the genomic DNA region 
outside the knock-out cassette and the other annealed within the genomic DNA 
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target region within the cassette generating a product for wild-type cells and all 
transformants. The VC reaction primers were designed so that one primer 
annealed within the genomic DNA region within the cassette and the other primer 
annealed to the blasticidin resistance gene, generating a product in cells 
successfully transformed with the knock-out cassette. The KO reaction used a 
primer from the GC reaction that is outside the targeting cassette and one primer 
within the blasiticidin resistance cassette from the VC reaction, this product will 
only be present in cells that have undergone homologous integration. These three 
PCR reactions were used to screen both the 5’ and 3’ regions of the modified 
gene with N- or C-terminal specific primers. To identify positive aph-1- cell lines, 
234 blasticidin resistant colonies were screened. From these screens, three 
positive homologous knock-out strains were found showing homologous 
integration in both the 5’ and 3’ regions of the aph-1 gene. Homologous integrants 
were serially diluted and plated onto SM Agar plates containing R. planticola to 
allow for isogenic cell line selection, these were then re-screened to allow for the 
selection of 3 independent isogenic homologous knock-out cell lines. 
 
84 
 
Figure 4.3. PCR Screening for homologous recombinants of aph-1-. A) Genomic control, 
vector control and knock-out diagnostic primers were designed to screen successful 
transformants for homologous recombination. B) Gel electrophoresis of PCR products from 
genomic DNA show only genomic control bands in wild-type (WT), genomic control and vector 
control bands in non-homologous recombinants (NH1), and genomic control, vector control, and 
knock-out diagnostic bands in homologous recombinants (KO1, KO2, KO3) for both N-terminus 
and C-terminus. C) RT-PCR using primers flanking the blasticidin cassette shows Aph-1 
expression in wild-type cells (472bp) but loss of expression in Aph-1 knock-out cell lines. 
Control bands show consistently expressed IG7 (559bp).   
 
In order to confirm gene ablation in the identified aph-1- cell lines a reverse 
transcriptase PCR (RT-PCR) was used (Figure 4.3 C). In these experiments 
cDNA was synthesised from aph-1- mutant cells and also from wild-type cells. 
The primers used in this PCR were designed to anneal to the genomic DNA 
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flanking the blasticidin resistance cassette. Using this approach, PCR analysis 
from cDNA from wild-type cells provided a 472 base pair band, this indicated 
transcription of aph-1 mRNA, which was absent in the aph-1 knock-out line. As a 
control for presence of succesfully synthesised DNA, primers amplifying a 559 
base pair region of the mitochondrial large subunit rRNA (Ig7) (Vinet et al., 2014) 
was used in the RT-PCR. To confirm that these products were generated from 
the cDNA templates, negative controls without reverse transcriptase were also 
used in the PCR. 
4.3 Creating a pen-2 knock-out mutant 
 In order to generate a pen-2 knock-out mutant, a knockout cassette was 
created. This cassette consisted of two regions of the pen-2 gene amplified 
through PCR. The N-terminal (5’) region of the cassette was amplified from 
genomic DNA upstream of pen-2 and the C-terminal (3’) region incorporated the 
entire second intron of pen-2 and genomic DNA downstream of the gene. The 
knockout cassette therefore resulted in a deletion of 372 base pairs from pen-2 
including upstream genomic DNA, intron 1 and part of exon 1. These 5’ and 3’ 
fragments were cloned into pLPBLP flanking a blasticidin resistance cassette and 
a series of restriction digests were carried out to confirm succesful cloning (Figure 
4.4) (Faix et al., 2004), the knock-out vector was then sequenced to confirm 
sequence identity. Wild-type Dictyostelium cells were then transformed with the 
entire linearised homologous recombination cassette and plated into 96 well 
plates to allow for selection using blasticidin (10g/mL) and subsequent growth 
of positive transformants. 
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Figure 4.4 Vector generation for a pen-2 knockout cassette. A) The knock-out vector 
consists of a 5’ and 3’ fragment of pen-2 genomic DNA. These fragments were amplified by 
PCR using primers containing cutsites for BamHI, PstI, NcoI, and KpnI. B) N-terminal’ (550bp) 
and C-terminal (682bp) fragments were cloned into the pLPBLP vector flanking a blasticidin 
resistance cassette. C) To confirm successful integration of 5’ and 3’ fragments, a series of 
restriction digests were used. Double digests of BamHI and PstI generated the correct 5’ 
fragment, and NcoI and KpnI generated the correct 3’ fragment, additionally a BamHI and KpnI 
digest generated a linearised homologous recombination cassette (2965bp) which would be 
used in electroporation. Single digests using BamHI, PstI, NcoI, and KpnI were used as controls 
to ensure adequate restriction digestion.  
 
To determine whether homologous recombinants were generated, pen-2 
transformants grown in the presence of blasticidin were screened by PCR. In 
these experiments a similar screening approach to that of aph-1 was used with 
primers combinations for the pen-2 knockout vector. In short there were three 
reactions, a genomic control (GC), a vector control (VC) and a knock-out 
diagnostic band (KO). Each combination of primers will give a different product 
with the genomic control band expected in all cell lines, the vector control band 
expected solely in those cells transformed with a knock-out cassette, and the KO 
band only in those cells that have undergone homologous recombination. In total 
276 different pen-2 colonies were screened with no homologous recombinants 
found.  
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Figure 4.5. PCR Screening for homologous recombinants of pen-2-. A) Genomic control, 
vector control and knock-out diagnostic primers were designed to screen successful 
transformants for homologous recombination. B) Gel electrophoresis of PCR products from 
genomic DNA show only genomic control bands in wild-type (WT), genomic control and vector 
control bands in non-homologous recombinants (NH1, NH2), for both N-terminus and C-
terminus. 
 
To aid in ablating pen-2 in Dictyostelium, a secondary pen-2 knockout construct 
was generated (Figure 4.6). This knockout construct incorporated more of the 
pen-2 open reading frame than previously, resulting in ablation of only 5 base 
pairs from exon 2 of the pen-2 gene. The 5’ and 3’ arms of homology were cloned 
into a pLPBLP knockout vector and cloning was confirmed through restriction 
digest and sequencing (Figure 4.6 C). The resultant construct was transformed 
into Dictyostelium cells, and positive transformants were screened by PCR to 
identify homologous recombinants (Figure 4.6 D). In total 232 different pen-2 
colonies were screened using this vector resulting in a total 508 colonies 
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screened with no homologous recombinants found. Unfortunately, the small size 
of the pen-2 gene makes it difficult to generate significantly different knockout 
cassettes and therefore further attempts to ablate this gene were abandoned. 
 
Figure 4.6 Vector generation of second pen-2- construct and PCR screening for 
homologous recombinants. A) The knockout construct for Pen-2 was generated through PCR 
amplification of 5’ and 3’ arms of homology from genomic DNA. B) The 5’ (471 bp) and 3’ (350 
bp) arms of homology were cloned into the target pLPBLP vector flanking a blasticidin 
resistance cassette gene. C) To confirm succesful integration of arms of homology into the 
target vector restriction digests were performed using the enzymes BamHI, PstI, NcoI and KpnI. 
Double digests confirmed the presence of both the 3’ and 5’ arms of homology, and a BamHI + 
KpnI digest generated the correct linearised knockout cassette. D) Genomic control, vector 
control and knock-out diagnostic primers were designed to screen succesful transformants for 
homologous recombination. Gel electrophoresis of resultant PCR products from genomic DNA 
results in only genomic control bands in wild-type cells (WT) and genomic control and vector 
control bands in non-homologous recombinants (NH 1 – 5) for the N-terminus. 
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4.4 Development of aph-1- and nicastrin-  mutants 
When Dictyostelium cells are starved of nutrients they begin to aggregate 
and form fruiting bodies over a 24 hour period. Previous research in Dictyostelium 
has indicated that the -secretase/Presenilin proteins contribute towards this 
process, however whether the entire protein complex is involved or only the 
presenilin proteins is controversial (McMains et al., 2010, Ludtmann et al., 2014). 
In this experiment wild-type cells were allowed to develop under three different 
developmental conditions, (1) on phosphate buffer soaked filter pads, (2) on 1% 
agar plates containing KK2 phosphate buffer, or (3) nitrocellulose filters placed 
on 1% agar plates with phosphate buffer. Under all three of these conditions wild-
type cells developed into fruiting bodies consisting of a basal disk, stalk and spore 
head (Figure 4.4 A, B, C).  
In order to investigate the effects of aph-1 ablation and nicastrin ablation 
(previously generated (Ludtmann et al., 2014)) on development aph-1- and 
nicastrin- cell development was analysed. When aph-1- mutants developed over 
24 hours we see different developmental phenotypes depending on the substrate 
used. When developed on nitrocellulose filters placed upon phosphate buffer 
soaked filter pads aph-1- cells generated wild-type morphology fruiting bodies 
(Figure 4.4 A). However, when developed on a substrate containing 1% agar, or 
a nitrocellulose membrane placed on top of a 1% agar plate these cells failed to 
form morphologically normal fruiting bodies, and development was arrested at 
the mound stage at 24 hours (Figure 4.4 B, C). Upon ablation of nicastrin, cells 
develop fully formed fruiting bodies on nitrocellulose filters over 24 hours (Figure 
4.4 A), however, when developed on agar plates these cells failed to form fruiting 
bodies within 24 hours. The data here concurs with, and confirms, previously 
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published data on the development of -secretase component null mutants, 
including presenilin, nicastrin and aph-1 (Ludtmann et al., 2014, McMains et al., 
2010). Additionally, the shared  block in development when incubated on agar 
observed across these mutants indicates an important role for the -secretase 
complex in Dictyostelium development. However, it is worth noting the different 
phenotypes observed upon developing these cells under different substrates, and 
the reasons underlying this warrant further research and study to determine the 
cause.  
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Figure 4.7 Effects of aph-1 and nicastrin ablation on Dictyostelium development. Wild-
type, aph-1-, and nicastrin- cells were developed on different developmental substrates over 24 
hours. Cells were developed on nitrocellulose filters placed on phosphate buffer soaked filter 
pads. Under these conditions wild-type, aph-1-, and nicastrin- cell lines all developed into wild-
type comparable fruiting bodies. When developed on 1% Agar containing phosphate buffer 
plates. Under these conditions wild-type cells developed into fruiting bodies over a 24 hour 
period, however aph-1-, and nicastrin- cells lines failed to develop in 24 hours and halted 
development at the mound stage. When developed on nitrocellulose membranes placed on 1% 
agar containing phosphate buffer plates. Under these conditions wild-type cells differentiate into 
mature fruiting bodies at 24 hours, but aph-1- cells exhibit similar developmental defects to 
those seen on 1% agar phosphate buffer plates and halt development at the mound stage. 
Scale bar denotes 0.5mm. 
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4.5 Growth rates of -secretase deficient Dictyostelium mutants 
Research investigating the roles of the -secretase complex in mammalian 
model organisms has implicated the complex in endocytosis (Tamboli et al., 
2008, Zhang et al., 2006). These studies have investigated macropinocytosis in 
cells lacking the protein complex, and show decreased rates of nutrient uptake 
upon ablation of presenilin (Tamboli et al., 2008, Zhang et al., 2006). Although 
these studies do not investigate growth rate, cells lacking the ability to 
macropinocytose nutrients efficiently could be expected to show a decreased 
growth rate, as these cells will be unable to take up sufficient nutrients compared 
to wild-type cells (Upadhyay and Shaw, 2008, Munn and Riezman, 1994, Otomo 
et al., 2008). An earlier study suggested that in Dictyostelium, the presenilin 
proteins function in phagocytosis, and phagocytic dependent growth in a -
secretase complex independent, but presenilin only catalytically dependent 
manner (McMains et al., 2010), however the effects of -secretase component 
ablation on macropinocytosis has not yet been investigated. 
In order to determine whether macropinocytosis in Dictyostelium is altered by -
secretase ablation, a simple growth assay was utilised. This growth assay 
monitored cell count in liquid medium, and cell density was calculated relative to 
wild-type cells (Figure 4.7). In these growth assays wild-type cells exhibit a lag 
phase, exponential phase, and plateau phase of growth. In these experiments 
cell number at day 7 was normalised to 100% to eliminate biological variance in 
cell number from experiment to experiment. Upon ablation of either aph-1 or 
ncstn cells grew comparably to control, with no significant difference in cell 
number (p=0.29 and p=0.23 respectively). Upon ablation of psenA/B however, 
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cells reached a 60% growth of wild-type cells indicating a role for this protein in 
Dictyostelium growth (p=0.0001) (Figure 4.7 A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 Growth rates of -secretase null Dictyostelium in liquid media. A) Under normal 
growth conditions in liquid media wild-type cells exhibit a typical lag, exponential and plateau 
phase. Aph-1- (P=0.29) and Ncstn- (P=0.23) cells exhibit no significant growth defects under 
these conditions. PsenA-/B- cells however, exhibit a 40% decrease in growth compared to wild-
type cells (P=0.0001). B) Further analysis of PsenA-/B- growth showed that expression of a 
catalytic, or non-catalytic PsenB rescue plasmid in PsenA-/B- cells restores growth levels to 
those of wild-type, rescuing the defects observed upon presenilin ablation (PsenA-/B- P=0.0007; 
PsenA-/B-::PsenB-GFP P=0.80; PsenA-/B-::PsenBDD P=0.78). 
A 
B 
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We next set out to determine whether the observed growth defect in liquid 
medium was dependent upon the catalytic activity of  the -secretase complex 
(Figure 4.7 B). Upon expression of catalytically active PsenB-GFP (Ludtmann et 
al., 2014) growth was restored to wild-type levels (p=0.80), rescuing the effects 
of presenilin ablation. Additionally, when expressing a catalytically inactive 
version of PsenB with mutated aspartate residues at positions 348, and 395 
(Ludtmann et al., 2014) growth rates are once again restored to those of wild-
type levels (p=0.78). These data suggest that in Dictyostelium the presenilin 
component of the -secretase complex has a function in growth in liquid media 
independent of the -secretase complex, and that this role is not dependent upon 
catalytic activity. 
4.6 -secretase localisation in null mutants 
 As the formation of the -secretase complex is sequential in mammalian 
models (De Strooper et al., 2012, Strooper, 2003, Mao et al., 2012), Aph-1 and 
Nicastrin first form an initial complex before being joined by Psen1 and Pen-2 
(Smolarkiewicz et al., 2013), we set out to determine whether the complex 
exhibits aberrant localisation upon component ablation. Utilising previously 
described overexpression constructs (Chapter III), we were able to visualise the 
localisation of fluorescently tagged Aph-1, Ncstn and PsenB in backgrounds 
lacking functional Aph-1 and PsenA/B.  
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Figure 4.9 
Localisation of -
secretase 
components in -
secretase null 
mutants. In cells 
lacking Aph-1 or 
PsenA/B the 
localisation of the -
secretase 
components Aph-1, 
PsenB and Ncstn is 
unaltered. 
Components are still 
localised to the 
endoplasmic reticulum 
as in wild-type 
counterparts (chapter 
III). Scale bar = 10m. 
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As shown in previous chapters, the -secretase complex localises to the 
endoplasmic reticulum in wild-type cells. This localisation corresponds with 
observations in mammalian model organisms (Smolarkiewicz et al., 2013, Xia et 
al., 1998). Upon ablation of Aph-1, one of the first two components to begin 
formation of the complex, localisation is unaltered (Figure 4.8). Furthermore, Aph-
1, PsenB, and Ncstn are still found to be localised to the ER. Similarly, upon 
ablation of PsenB, the localisation of these components remains at the ER and 
is therefore unaltered.   
4.7 Discussion 
 Understanding the basic function of the components of the -secretase 
complex is important in order to understand the physiological role of this protein 
complex. Dictyostelium provides a useful model organism for this purpose as it is 
a haploid organism gene ablation does not require ablation of two copies of each 
gene compared to mammalian model organisms. Additionally, in this model 
organism there is no embryonic lethality upon -secretase ablation as there is in 
mammalian organisms (Otto et al., 2016, Ludtmann et al., 2014, McMains et al., 
2010, De Strooper et al., 2012). Dictyostelium has also been used to determine 
catalytic and non-catalytic presenilin functions, as well as showing evolutionary 
conservation between Dictyostelium and man (Ludtmann et al., 2014, McMains 
et al., 2010). 
In this chapter we described the ablation of aph-1 in Dictyostelium by generating 
a null cell line with a 17% deletion of the central region of the encoding gene 
through homologous recombination. We confirmed loss of aph-1 expression 
through RT-PCR after deletion. Additionally, we attempted to ablate 
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Dictyostelium pen-2, but were unsuccesful. The small coding region of pen-2 
renders it difficult to delete as a small, low specificity targeting region reduces the 
likelihood or homologous crossover, and therefore we have not continued to 
investigate this protein. Alternatives to gene ablation may be utilised in the future 
such as RNAi (Martens et al., 2002). Finally, we have investigated the effects of 
-secretase ablation using cell lines lacking aph-1, ncstn, and psenA/B in 
development, growth and component localisation to determine whether these 
functions are complex dependent or independent.   
The role of the -secretase complex in Dictyostelium development remains to be 
fully explored. Previous studies in this model organism have demonstrated a 
common role for PsenA/B in Dictyostelium development (Ludtmann et al., 2014, 
McMains et al., 2010), however differing results have been found for cell lines 
lacking Ncstn (McMains et al., 2010, Ludtmann et al., 2014). In this chapter we 
have shown that Dictyostelium cell lines lacking aph-1 and ncstn develop 
differently depending on the substrate they are incubated upon. When these cell 
lines are developed on nitrocellulose filters they form wild-type morphology 
fruiting bodies (Ludtmann et al., 2014), however, when these cell lines are 
incubated upon phosphapte buffered agar plates they show a similar 
developmental phenotype to PsenA/B null cell lines halting development at the 
mound or first finger stage (McMains et al., 2010). These data confirm the findings 
of both earlier studies and suggests a function for the entire -secretase complex 
in Dictyostelium dependent upon external factors such as developmental 
substrate. 
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The -secretase complex/Presenilin proteins have been implicated in uptake 
through macropinocytosis and phagocytosis in mammalian model organisms and 
Dictyostelium (Cataldo et al., 2000, Tamboli et al., 2008, Jutras et al., 2005, 
McMains et al., 2010). Previous research using Dictyostelium has indicated an 
important role for presenilin in nutrient uptake through phagocytosis dependent 
upon catalytic activity (McMains et al., 2010), here we show  that in addition to 
this role in phagocytosis the presenilin proteins also have a function related to 
fluid phase nutrient uptake and that this function is not dependent upon the 
catalytic activity of the protein. We demonstrate here that Presenilin B, but not 
Aph-1 or Ncstn, also function in nutrient uptake in liquid media and that this 
function is not dependent upon catalytic activity. This data suggests a potential, 
previously unknown, role of presenilin in the mediation of fluid-phase uptake by 
this protein in Dictyostelium. The role of presenilin in fluid-phase nutrient uptake 
has been investigated in mammalian model organisms (Tamboli et al., 2008, 
Zhang et al., 2006, Cataldo et al., 2000). These studies show that in mouse 
embryonic fibroblasts, ablation of presenilin or usage of chemical -secretase 
inhibitors, but not Alzheimer’s disease causing mutations, results in impaired  
lipoprotein particle uptake, and subsequent decreased protein clearance from the 
endocytic pathway (Tamboli et al., 2008, Zhang et al., 2006).  Additionally, in 
mammalian organisms it has been found that ablation of Presenilin results 
abnormalities in the endocytic pathway which precede the deposition of 
neurotoxic A42 plaques and Alzheimer’s disease progression (Cataldo et al., 
2000). This is the first time, to our knowledge, that Presenilin has been implicated 
in Dictyostelium fluid phase nutrient uptake. Whilst the roles for endocytosis differ 
between mammalian neurons, where the function of endocytosis is not to engulf 
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nutrients, but rather lipoprotein particles and neurotransmitters (Cosker and 
Segal, 2014), and Dictyostelium where the function is nutrient uptake for growth, 
the abnormalities observed here in fluid-phase uptake upon Presenilin ablation 
are conserved across these two species suggesting an ancenstral role for this 
protein in this role. 
Previously in this thesis we have shown that the localistion of -secretase 
components in Dictyostelium is conserved between mammalian model systems 
and Dictyostelium, and that the components Aph-1, Ncstn and PsenB localise to 
the endoplasmic reticulum. The localisation of the -secretase components in the 
absence of other constituents, however, has not been investigated before. 
Utilising immunoprecipitation researchers have demonstrated that the formation 
of the -secretase complex is sequential in mammalian model organisms (Mao et 
al., 2012), where Aph-1 and Ncstn first form an initial holocomplex, before being 
joined by Presenilin and finally Pen-2 (Mao et al., 2012). Our study shows that 
upon ablation of Aph-1 or PsenA/B, localisation of the other complex 
components, Aph-1, Ncstn and PsenB, are unaltered in Dictyostelium. With 
regards to these data it is possible that Aph-1 and Ncstn have unaltered 
localisation in null backgrounds as these components form the intial scaffold of 
the -secretase complex (Smolarkiewicz et al., 2013) and therefore will localise 
to their appropriate cellular compartments regardless of the presence of other 
components. In contrast, in mammalian models Psen1, requires an Aph-1/Ncstn 
complex to form before it is able to join the -secretase complex and therefore 
unaltered localisation may be due to a distnict mechanism of component 
localisation to that shown in mammalian models, erroneous localisation due to 
protein overexpression, or abberant protein localisation due to GFP-tagging 
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proteins (Gahlmann and Moerner, 2014). Whilst our study does demonstrate that 
the protein localisation is not altered when compared to mammalian model 
organisms an alternative approach utilising knock-in tagged proteins may allow 
for greater insight into protein localisation in Dictyostelium in the presence or 
absence of other complex components. 
In this chapter we have examined Dictyostelium development, growth and -
secretase component localisation in cell lines lacking -secretase components. 
We show that in the absence of Aph-1 and Ncstn, Dictyostelium development is 
dependent upon developmental substrate. Additionally we show that the ablation 
of Presenilin B decreases Dictyostelium growth in liquid media, demonstrating a 
conserved role for this protein in fluid-phase uptake previously suggested in 
mammalian organisms (Fukumori et al., 2006, Tamboli et al., 2008, Zhang et al., 
2006). Finally we demonstrate that in Dictyostelium upon ablation of Aph-1, or 
PsenB localisation of -secretase components is unaltered and these proteins 
continue to localise to the ER, however, this work utilised overexpression 
constructs which may present their own difficulties (Gahlmann and Moerner, 
2014), and so alternative methods may be more beneficial such as knock-in 
approaches (Hanks et al., 1995). 
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Chapter V 
The Role of the Dictyostelium -Secretase 
Complex in Macropinocytosis and 
Autophagy 
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5.1 Introduction 
 The central function of the -secretase complex has been thought to be 
through its proteolytic cleavage of target substrates (De Strooper, 2003, De 
Strooper et al., 1998, Zhang et al., 2000, Zhao et al., 2010). In this role the 
catalytic component of the complex, Presenilin, is required to cleave a wide 
variety of substrates including Alzheimer’s disease related amyloid precursor 
protein (De Strooper et al., 1998), and developmental protein Notch (Zhao et al., 
2010). Alongside these proteolytic functions several non-proteolytic roles have 
also been suggested, relying on a scaffolding function of the complex 
(Khandelwal et al., 2007, Otto et al., 2016, Ludtmann et al., 2014, Dobrowolski et 
al., 2012, Murayama et al., 1998, Zhang et al., 1998). Within this subset of roles, 
a number of studies have investigated the role of the -secretase 
complex/Presenilin in mammalian endocytosis and autophagy (Esselens et al., 
2004, Lee et al., 2015, Lee et al., 2010, Neely et al., 2011, Cataldo et al., 2000, 
Tamboli et al., 2008, Zhang et al., 2006), however it is not known whether these 
processes rely on the entire -secretase complex, presenilin proteins alone, or 
whether proteolytic activity also plays a role. 
Other roles for the -secretase complex have also been suggested. In 
mammalian model organisms, -secretase /Presenilin has been found to be a 
crucial component for efficient protein clearance from the endocytic recycling 
compartment (Zhang et al., 2006), and for normal endocytic uptake of lipoprotein 
particles (Tamboli et al., 2008). Utilising Chinese hamster ovary cells it was 
shown that treatment with the -secretase inhibitor DAPT retained 2 – 3 times the 
amount of fluorescently labelled transferrin for a greater measurement of time 
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when compared to wild-type cells, this was also found with cells lacking the 
Presenilin proteins and cells with ablated catalytic activity (Zhang et al., 2006). 
Additionally, analysis with FITC-Dextran, a late endosomal marker, showed no 
significant co-localisation between labelled transferrin and FITC-Dextran in cells 
lacking Presenilin/-secretase activity. Through the use of mouse embryonic 
fibroblasts, and mouse neurons, with ablated Presenilin proteins, or transgenic 
expression of AD causing mutated Presenilin, researchers have demonstrated 
that loss of the -secretase complex results in diminished uptake of lipoproteins 
through a mistargeting of proteins responsible for endocytic regulation of the LDL 
receptor causing elevated levels of apolipoprotein E in these cells (Tamboli et al., 
2008). These mammalian studies establish a link between endocytosis and the 
-secretase complex, but unfortunately are not able to distinguish between roles 
dependent upon the complex as a whole, and roles dependent upon only the 
Presenilin proteins. 
 The role of the -secretase complex/Presenilin in autophagy has also been 
investigated in mammalian model organisms (Lee et al., 2015, Lee et al., 2010, 
Neely et al., 2011, Wolfe et al., 2013). Studies exploring this function of -
secretase have implicated insufficient lysosomal acidification as a key factor in 
autophagic disruption in these model organisms. Upon ablation of presenilin, 
Presenilin null mouse blastocysts demonstrate elevated lysosomal pH as a result 
of dysfunctional v-ATPase subunit localisation, a phenotype shared in cells 
expressing AD causing Presenilin mutations (Lee et al., 2010). Additionally, cells 
lacking Presenilin exhibit an accumulation of autophagosomes, indicative of 
autophagy disruption, that is not present upon halting -secretase proteolytic 
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activity through the use of complex specific inhibitors (Neely et al., 2011). These 
results are consistent when examined in fibroblasts from AD patients with AD 
causing -secretase complex mutations (Wolfe et al., 2013). The proposed 
mechanism for this defect in lysosomal acidification is aberrant calcium 
homeostasis as a result of presenilin ablation, a function shown to be -secretase 
independent (Sarasija and Norman, 2015), however restoration of intracellular 
calcium concentration to wild-type levels did not rescue the defects observed in 
autophagy upon Presenilin ablation (Lee et al., 2015). These studies demonstrate 
an important role for the -secretase complex/ Presenilin in maintaining 
autophagy/lysosomal acidification in mammalian model organisms, but once 
again do not shed light upon whether this function is due to the entire complex, 
presenilin alone, or proteolytic activity. 
 
Figure 5.1 The Effects of Presenilin Ablation on Autophagy. A) In wild-type cells autophagy 
progresses as follows: Formation of isolation membrane, collection of cellular components for 
degradation, fusion of autophagosome with lysosome, subsequent degradation of cellular 
material. B) In the absence of Presenilin the pH in the lysosome is elevated, therefore 
decreasing the degradation of material contained within the autophagosome causing a 
decrease in the rate of autophagy and resulting in an accumulation of autophagosomes. 
 
A B 
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Dictyostelium has been established as a model organism for the investigation of 
endocytosis and autophagy, often resulting in translation to mammalian model 
systems (Annesley et al., 2011, Chubb et al., 2000, Commisso et al., 2013, King 
et al., 2013).  Dictyostelium mutants lacking autophagy related proteins 
demonstrate differing developmental defects dependent upon developmental 
substrate as observed in mutants lacking Aph-1 and Ncstn (Chapter 4.4). 
Additionally, Dictyostelium has been used to demonstrate a non-catalytic role of 
Presenilin in Dictyostelium development, with conserved function when 
expressing the human Presenilin 1 protein (Ludtmann et al., 2014), and has 
shown a Presenilin function in Dictyostelium phagocytosis in a catalytic 
dependent manner (McMains et al., 2010) providing a useful model organism for 
investigating the effects of -secretase ablation in endocytosis and autophagy. 
This chapter will report on the use of Dictyostelium to investigate the role of the 
-secretase complex in Dictyostelium endocytosis, specifically macropinocytosis, 
and Dictyostelium autophagy. Use of this model organism will allow for 
differentiation between roles dependent upon the entire protein complex or 
Presenilin only functions, as well as roles dependent upon catalytic activity. This 
approach will allow the exploration of evolutionarily conserved function by 
expressing human presenilin proteins in psenA-/B- cells. 
5.2 Macropinocytosis in -secretase Component Null Mutants 
As endocytic uptake is inhibited upon presenilin ablation in mammalian 
organisms (Tamboli et al., 2008) we set out to determine whether the dominant 
form of fluid phase uptake in Dictyostelium - macropinocytosis, is also inhibited 
upon presenilin/-secretase ablation. Utilising the fluorescently labelled dextran, 
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TRITC-Dextran, we can measure fluid phase nutrient uptake, and therefore 
quantify uptake corresponding to macropinocytosis in Dictyostelium cells (Hacker 
et al., 1997). 
Figure 5.2 Macropinocytosis in Dictyostelium -secretase mutants. A) Representative 
images of TRITC-Dextran uptake in Dictyostelium cells over 60 minutes. B) TRITC-Dextran 
uptake in wild-type, ncstn-, aph-1-, and psenA-/B- Dictyostelium cells. Normalised against wild-
type cells Dictyostelium -secretase mutants show a decrease in TRITC-Dextran uptake through 
macropinocytosis. C) TRITC-Dextran uptake in wild-type, psenA-/B-, and Dictyostelium 
catalytically active and inactive rescues show restoration of TRITC-Dextran uptake regardless of 
Presenilin catalytic activity compared to psenA-/B- cells. D) TRITC-Dextran uptake in wild-type, 
psenA-/B-, and human catalytically active and inactive rescues show restoration of TRITC-
Dextran uptake regardless of Presenilin catalytic activity compared to psenA-/B- cells. E) Rates 
of TRITC-Dextran uptake comparing wild-type, -secretase null mutants, and Dictyostelium and 
human Presenilin rescue mutants.  
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Using the first 60 minutes of macropinocytosis when uptake of TRITC-Dextran is 
linear (Figure 5.2 B) the rate of fluid phase uptake can be calculated. In this 
experiment, wild-type cells showed a rate of 1±0.25 RFU/min/2.5x106 cells whilst 
cells lacking Aph-1 (Figure 5.2 C), Ncstn and Presenilin showed decreased rates 
of 0.6±0.05, 0.65±0.15, 0.5±0.05 RFU/min/2.5x106 cells respectively. These data 
indicate that the entire -secretase complex functions to ensure normal 
macropinocytosis in Dictyostelium, and not only the Presenilin proteins. 
As Presenilins show both catalytic and non-catalytic functions we next sought to 
determine whether macropinocytosis is dependent upon -secretase proteolytic 
activity. Expression of a catalytically active PsenB-GFP in psenA-/B- cells 
restored macropinocytosis to wild-type levels (1.26±0.4 RFU/min/2.5x106 cells) 
(Figure 5.2 B, C), as did expression of the catalytically inactive PsenBDD-GFP 
lacking residues D348 and D394 catalytic (0.98±0.12 RFU/min/2.5x106 cells) 
indicating that this role is not dependent upon proteolytic activity. Further, 
expression of a human Presenilin 1 protein also rescued macropinocytosis 
defects due to Presenilin ablation, once again in the presence or absence of 
catalytic activity (1.1±0.3, and 1.2±0.2 RFU/min/2.5x106 cells respectively).  
5.3 The Effects of pH on -secretase Mutant Development 
 Since in mammalian models, -secretase/presenilin ablation gives rise to 
increased lysosomal pH we set out to determine whether vesicle acidification in 
Dictyostelium is also perturbed upon -secretase/presenilin ablation. One 
approach to identifying acidification defects in Dictyostelium was illustrated in the 
study of the vesicle acidification mutant hgr5- (Davies et al., 1996). These cells 
fail to form terminal developmental structures under neutral pH but exhibit an 
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increased sensitivity to developmental pH and are further delayed when 
developed in the presence of weak bases (Davies et al., 1996). Additionally, the 
role of acidification in development was confirmed by development in acidic 
conditions where the developmental defects observed at neutral pH are rescued 
(Davies et al., 1996). In order to determine whether Dictyostelium -secretase 
mutants exhibit vesicular acidification defects -secretase null cell lines were 
developed under a variety of pH conditions. In these experiments, aph-1-, ncstn- 
and psenA-/B- cells were developed at pH 7, pH 8 and pH 9 on nitrocellulose 
membranes. Here, wild-type cells formed mature fruiting bodies consisting of a 
basal disk, stalk and spore head under all conditions (Figure 5.3 A). In contrast, 
aph-1- and ncstn- cells formed fruiting bodies at pH 7 as shown previously (Figure 
5.3 B), but failed to develop beyond the first finger stage at pH 8 and pH 9 (Figure 
5.3 B). psenA-/B- cells failed to develop fruiting bodies at pH 7 as shown 
previously (Ludtmann et al., 2014) and were halted at the earlier mound stage at 
the more basic pH 9 (Figure 5.3 A).These data indicate -secretase component 
null mutants possess a sensitivity to basic pH suggesting a vesicle acidification 
defect. 
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Figure 5.3 Development of Dictyostelium -secretase null mutants under basic pH. A) 
Under basic conditions wild-type cells develop normal morphology fruiting bodies. psenA-/B- 
cells fail to develop at pH 7 and are further inhibited at pH 8 and pH 9. B) aph-1- and ncstn- cells 
develop normal morphology fruiting bodies at pH 7, but fail to develop at pH 8 and pH 9 
indicating increased sensitivity to pH.  
 
110 
 
Figure 5.4 
Development of 
Dictyostelium -
secretase null 
mutants under 
acidic pH. A) 
Under acidic 
conditions wild-
type cells form 
normal morphology 
fruiting bodies. 
psenA-/B- cells are 
partially rescued at 
pH 5, forming 
smaller sized 
fruiting bodies 
consisting of a 
basal disk, stalk 
and spore head. B) 
Presenilin rescue 
mutants are able to 
develop at pH 7 
and under acidic 
pH conditions 
regardless of 
catalytic or non-
catalytic activity, 
replicating wild-
type cells. 
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As PsenA-/B- mutants fail to develop at neutral pH when compared to wild-type 
and Aph-1-, Ncstn- cells we next set out to examine whether this developmental 
defect can be rescued under acidic pH conditions. In these experiments, psenA-
/B- cells were developed under acidic pH conditions at pH 6, and pH 5 alongside 
wild-type cells. Under these conditions, wild-type cells formed mature fruiting 
bodies at both acidic pHs (Figure 5.4 A) whilst psenA-/B- cells formed 
morphologically normal, but smaller in size, fruiting bodies at pH 5 (Figure 5.4 A) 
indicating a partial rescue. These results suggested that the developmental 
defect observed in PsenA-/B- cells is partially due to a pH imbalance within these 
cells. Importantly, Presenilin mutants rescued by catalytically active or inactive 
Dictyostelium Presenilin B, or human Presenilin 1 constructs were unaffected by 
pH conditions and developed morphologically normal fruiting bodies (Figure 5.4 
B). These results suggest that vesicle acidification in Dictyostelium is not reliant 
upon the catalytic activity of the -secretase complex, but rather a non-catalytic 
scaffolding function that has been conserved through evolution. 
5.4 The Effects of -secretase Ablation on Autophagy and Protein 
Ubiquitination 
As autophagy is required for development in Dictyostelium (Otto et al., 
2004), we sought to determine whether autophagy is also disrupted in cells 
lacking functional Presenilin/-secretase, and to establish whether this role is 
carried out by Presenilin alone or by the entire protein complex. Dictyostelium 
cells defective in autophagy show large aggregates of the autophagy protein 
marker GFP-Atg8 (Calvo-Garrido and Escalante, 2010, Otto et al., 2004, King et 
al., 2011). Measurement of GFP-Atg8 positive aggregates in Dictyostelium was 
achieved by expressing GFP-Atg8 in wild-type cells, cells lacking PsenA and 
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PsenB, and cells lacking Aph-1 were visualised under agarose to stimulate 
autophagy (King et al., 2011). In these experiments, wild-type cells show a 
majority (79%) of small diameter autophagosomes (below 0.4m) with very few 
structures (1.4%) above 0.8m (Figure 5.5 A, C) indicating normally functioning 
autophagy. Upon ablation of aph-1 cells showed a significant decrease (p<0.01) 
of autophagosomes below 0.4m (26%) and a significant increase (p<0.05) in 
large diameter autophagosomes (17%) (Figure 5.5 A, C). Similarly, cells lacking 
Presenilin showed a significant decrease (p<0.05) in small autophagosomes 
(38%) and a significant increase in large (greater than 0.8m) GFP-Atg8 positive 
structures (p<0.001, 18%) (Figure 5.5 B, C). These data suggest that loss of the 
-secretase complex causes autophagic dysfunction. 
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Figure 5.5 Localisation and size measurement of GFP-Atg8 positive vesicles in 
Dictyostelium. A) Wild-type cells expressing GFP-Atg8 show several GFP positive puncta per 
cell. A proportion of aph-1- cells show a distinct, single, large GFP-positive punctum (white 
arrow heads). B) psenA-/B- cells also exhibit a single, large, GFP positive puncta in a portion of 
cells. Presenilin rescue constructs expressed in psenA-/B- cells show a restoration of the wild-
type GFP-Atg8 localisation, restoring localisation to several small puncta per cell. C) 
Quantification of GFP-Atg8 puncta show that wild-type cells exhibit a majority of small GFP-
positive puncta with very few medium or large sized puncta. Aph-1- and PsenA-/B- cells exhibit a 
significant decrease in small GFP positive puncta and a significant increase in large (>0.8m) 
puncta. D) Expression of catalytically active or inactive Dictyostelium PsenB rescues GFP-Atg8 
puncta defects observed in psenA-/B- cells. E) Expression of a catalytically active or inactive 
human Psen1 restores GFP-Atg8 puncta defects observed upon presenilin ablation in 
Dictyostelium.  
 
To determine whether the role of the -secretase complex in autophagy is 
dependent upon catalytic activity GFP-Atg8 was co-expressed in cells expressing 
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Dictyostelium catalytically active or inactive Presenilin B, and in cells expressing 
human catalytically active or inactive Presenilin 1. In all cases, restoration of 
Presenilin rescued the autophagic defects observed in psenA-/B- cells (Figure 5.5 
B, D, E). These results confirm that this function of the -secretase complex is not 
reliant upon catalytic activity, but rather a scaffolding function, and is conserved 
with the human Presenilin protein. 
A typical response to autophagic dysfunction is the accumulation of high 
molecular weight ubiquitinated protein (Calvo-Garrido and Escalante, 2010). 
Large GFP-Atg8 positive aggregates show co-localisation with ubiquitin, and 
increased high molecular weight ubiquitin in western blot (Calvo-Garrido and 
Escalante, 2010). To investigate this effect in relation to loss of -secretase 
components, cells expressing GFP-Atg8 were fixed in -80°C methanol and 
stained for GFP and ubiquitin. In these experiments, wild-type cells exhibited 
GFP-positive puncta and generalised ubiquitin staining with no co-localisation 
(Figure 5.6 A). Following Aph-1 or PsenA/B ablation a portion of cells exhibited a 
single GFP-positive punctum that was also positive for ubiquitin which was not 
observed in wild-type cells. When Presenilin constructs were expressed in psenA-
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/B- cells GFP-Atg8 no longer co-localised with ubiquitin, and the majority of GFP-
positive puncta were <0.4m regardless of catalytic activity.  
Figure 5.6 High molecular weight ubiquitin aggregation and localisation in Dictyostelium 
-secretase mutants.  A) Wild-type cells fixed and stained for GFP and ubiquitin exhibit typical 
small GFP-Atg8 positive puncta and non-specific ubiquitin staining. Aph-1- and psenA-/B- cells 
exhibit co-localisation between GFP-Atg8 and ubiquitin not observed in wild-type cells (White 
arrow heads). Upon expression of PsenB or Psen1 GFP-Atg8 localisation was rescued, no 
longer co-localising with ubiquitin. Scale bar = 10m. 
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Figure 5.7 Quantification of high molecular weight ubiquitin in Dictyostelium -secretase 
mutants. A) Western blot analysis demonstrates an increased level of high molecular weight 
ubiquitin in cells lacking aph-1 and psenA/B which is not observed upon expression of 
catalytically active or inactive Dictyostelium PsenB or human Psen1. B) Quantification of high 
molecular weight ubiquitin shows a significant increase in cells lacking Aph-1 and PsenA/B, this 
is restored upon expression of catalytically active or inactive PsenB or Psen1. 
 
Quantification of high molecular weight ubiquitin can be determined through 
western blot. These assays usually utilise cells expressing GFP-Atg8 (Calvo-
Garrido and Escalante, 2010, Xiong et al., 2015), however it is not known whether 
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the presence of GFP-Atg8 affects the presence of ubiquitinated protein. In order 
to ensure that expression of GFP-Atg8 did not affect these experiments we 
utilised wild-type cells and base null strains psenA-/B-, and aph-1- for analysis. In 
this assay, high molecular weight ubiquitin was quantified and normalised to wild-
type levels using the loading control endoplasmic reticulum protein PDI (Figure 
5.7 A, B) (Muller-Taubenberger et al., 2001). Ablation of Aph-1 resulted in 
increased high molecular weight ubiquitin, increasing levels to 155±12% (p = 
0.0002) of wild-type cells (Figure 5.7 A, B), ablation of PsenA/B also resulted in 
an increase of 146±10% (p = 0.0001) compared to wild-type cells suggesting a 
dysfunction in protein degradation in these mutants (Figure 5.7 A, B). Restoration 
of Dictyostelium or human Psen (catalytically active or inactive) reversed the 
observed increase in high molecular weight ubiquitin. 
5.5 -secretase Ablation Causes Vesicle Acidification Defects 
 Degradation of intracellular components by autophagy is reliant upon 
lysosomal activity (Luzio et al., 2000). We therefore investigated the acidification 
of autophagosomes in cells lacking -secretase components. The fluorescence 
of GFP-Atg8 is quenched when exposed to acidic conditions (such as those found 
in lysosomes) (Figure 5.8 A) and so we analysed the GFP quenching time in wild-
type cells and cells lacking Aph-1 and PsenA/B to indirectly measure lysosomal 
pH. In these experiments, wild-type cells exhibited an average GFP quenching 
time of 35.3±6.8 seconds (Figure 5.8 B). Loss of Aph-1 significantly increased 
quenching time to 49.8±6.8 seconds (p<0.0001), and loss of PsenA/B also 
significantly increased quenching time to 46.4±9.7 seconds (p<0.0001) indicating 
a dysfunction in lysosomal acidification in these mutants. Expression of 
Dictyostelium catalytically active PsenB rescued this acidification defect 
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(32.2±4.7 seconds) as did expression of a catalytically inactive PsenB (31.5±6.5 
seconds). Similarly, expression of the catalytically active or inactive human Psen1 
proteins also rescued acidification (32.8±6.4 seconds and 28.8±5.6 seconds 
respectively). Therefore, we suggest that these acidification defects are reliant 
upon the -secretase complex, through a non-catalytic role, that is conserved 
from Dictyostelium to man. 
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Figure 5.8 Acidification of autophagosomes in Dictyostelium -secretase null mutants. A) 
Representative images of GFP-Atg8 quenching in Dictyostelium wild-type cells. B) 
Quantification of GFP-Atg8 quenching shows a significant increase upon ablation of Aph-1 or 
PsenA/B. Restoration of Presenilin activity restores GFP quenching to wild-type levels rescuing 
acidification defects observed upon presenilin ablation. Catalytically inactive Presenilin proteins 
are also able to restore acidification to wild-type levels.  
An alternative process reliant upon lysosomal acidification for normal function is 
phagocytosis (King et al., 2013). Since presenilin has been previously implicated 
in Dictyostelium phagocytosis we sought to determine whether this was also due 
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to acidification defects (McMains et al., 2010). To investigate this, a set of 
experiments were conducted by Dr. Jason King (University of Sheffield) to 
measure the acidification of phagosomes by measuring the proteolysis of beads 
coated with the self-quenching dye (DQ-BSA) which fluoresces upon proteolysis. 
This assay showed wild-type proteolytic activity measured at 1±0.3 a.u and 
ablation of Aph-1 or PsenA/B resulted in a significant reduction in proteolytic 
activity to 0.41±0.07 a.u (p=0.05) and 0.42±0.22 a.u (p=0.03) respective to wild-
type cells (Appendix 4). Expression of catalytically active or inactive Dictyostelium 
PsenB restored proteolysis to 0.79±0.24 a.u (p=0.1) and 1.29±0.5 a.u (p=0.36) 
compared to wild-type cells, and expression of a human active or inactive Psen1 
restored degradation rate to 0.99±0.22 a.u (p=1.00) and 1.21±0.16 a.u (p=0.35). 
These data suggest that in Dictyostelium lysosomal activity depends upon the 
entire -secretase complex and functions through a non-catalytic mechanism that 
is conserved with the human Presenilin proteins. 
5.6 Discussion 
 In this chapter, we have shown that the Dictyostelium -secretase complex 
plays an important role in Dictyostelium macropinocytosis, and phagocytosis 
through reduced vesicle acidification leading to defects in autophagy. We suggest 
that the most likely mechanism responsible for these defects is dysfunctional 
lysosomal acidification. Recent studies in mammalian organisms have 
investigated the roles of -secretase in vesicular trafficking and implicate 
dysfunction of these processes in the pathology and progression of Alzheimer’s 
disease (Cataldo et al., 2000, Fukumori et al., 2006, Tamboli et al., 2008, Zhang 
et al., 2006, Esselens et al., 2004, Lee et al., 2015, Lee et al., 2010, Neely et al., 
2011, Wolfe et al., 2013). These studies typically indicate that presenilin is the 
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protein component responsible for aberrant intracellular degeneration, and do not 
determine whether the entire complex is also involved (Esselens et al., 2004, Lee 
et al., 2015, Neely et al., 2011, Zhang et al., 2006). Here, we employed the social 
amoeba Dictyostelium as a model organism to investigate these processes and 
determine if presenilin alone or the entire -secretase complex is necessary for 
optimal vesicle acidification. We show that in Dictyostelium the entire -secretase, 
and not only presenilin, is necessary to enable normal macropinocytosis and 
autophagy, additionally we demonstrate that these processes are not reliant upon 
the catalytic activity of the complex where the role is conserved between the 
Dictyostelium Presenilin B and the human Presenilin 1 proteins. 
We show that upon ablation of -secretase components macropinocytosis, the 
main mechanism used by laboratory strain Dictyostelium to ingest nutrients 
(Bloomfield et al., 2015), is dysfunctional. Dictyostelium has been used to 
investigate the mechanisms behind macropinocytosis leading to discoveries 
including the role of RasS (Chubb et al., 2000), PI3-kinases (Hoeller et al., 2013), 
WASH (Buckley et al., 2016) and Neurofibromin (Bloomfield et al., 2015) in 
macropinocytosis, that have been replicated in mammalian organisms 
(Gopaldass et al., 2012, Sasaki et al., 2007, Buckley et al., 2016). Our data now 
suggests, for the first time, that a functional and complete -secretase complex is 
required for macropinocytosis in Dictyostelium in a structural role. In mammalian 
studies it has been unclear thus far whether presenilin alone or an entire -
secretase complex functions in macropinocytosis (Zhang et al., 2006) that may 
contribute to Alzheimer’s disease progression (Cataldo et al., 2000).  Mammalian 
studies utilising Psen null mutants, or -secretase inhibitors, are unable to 
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determine whether the processes investigated are due to the absence of 
presenilin as a complex-independent protein or due to the absence of -secretase 
as a protein complex (Zhang et al., 2006).  Here, we demonstrate, that the entire 
-complex and not only presenilin functions to mediate macropinocytosis, and 
further show conservation of this function between catalytically active or inactive 
Dictyostelium Presenilin and human Presenilin proteins. 
After internalisation, extracellular material is moved through the endocytic 
pathway before fusion with lysosomes causes vesicular material degradation 
(Gruenberg and Maxfield, 1995, Luzio et al., 2000). Dictyostelium mutants that 
are unable to properly acidify intracellular vesicles have been shown to be pH 
sensitive when undergoing development (Davies et al., 1996). As mammalian 
cells lacking presenilin proteins show defects in acidification (Lee et al., 2015, 
Lee et al., 2010, Wolfe et al., 2013) we sought to determine whether these 
proteins also function in acidification in Dictyostelium. Here, we have 
demonstrated that Dictyostelium -secretase mutants exhibit sensitivity to pH 
when undergoing development, suggesting defective vesicular acidification. 
Additionally, we show that defects arising from presenilin ablation are rescued 
through expression of non-catalytic Dictyostelium and human presenilin proteins. 
Our data indicate that normal Dictyostelium vesicular acidification is dependent 
upon a complete -secretase complex, and not only the presenilin proteins, in a 
non-catalytic manner that has been conserved between Dictyostelium and man 
which has not been shown previously. 
Autophagy, the process by which cells degrade intracellular material, is another 
cellular process dependent upon lysosomal degradation (Mizushima et al., 2002). 
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Dictyostelium as a model organism has been widely used to investigate 
autophagy and its role in multicellular development (Calvo-Garrido and 
Escalante, 2010, King et al., 2013, King et al., 2011, Otto et al., 2004, Xiong et 
al., 2015). Additionally, autophagic dysfunction has been implicated in 
Alzheimer’s disease where Presenilin is suggested to function in a complex 
independent role to maintain lysosomal pH, and that this disruption leads to 
increased build-up of neurotoxic peptides in patient neurons (Ghavami et al., 
2014, Lee et al., 2015, Lee et al., 2010, Neely et al., 2011, Wolfe et al., 2013). In 
mammalian studies, cells lacking Psen1 exhibit aggregation of the 
autophagosome marker apg12 and the neuronal protein telencephalin (Esselens 
et al., 2004). These aggregates are likely to be due to deficiencies in the ubiquitin 
proteasomal system, and are supressed through the expression of FAD-linked 
presenilin mutants suggesting it is not dependent upon catalytic activity (Esselens 
et al., 2004). However, whether this defect is dependent upon the presenilin 
proteins as a component of the -secretase complex, or solely the presenilin 
proteins is not understood. Here, we show that cells lacking -secretase 
components share hallmark characteristics with autophagy dysfunctional 
mutants, including aberrant GFP-Atg8 localisation, co-localisation of GFP-Atg8 
and ubiquitin aggregates and increased high molecular weight ubiquitin (Calvo-
Garrido and Escalante, 2010, Otto et al., 2004, Xiong et al., 2015). We further 
demonstrate that these deficiencies in autophagy are not dependent solely upon 
the presenilin proteins and can be rescued through non-catalytic Dictyostelium or 
human presenilin expression demonstrating a scaffolding role for the entire -
secretase complex in Dictyostelium autophagy conserved between Dictyostelium 
and man. 
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As autophagy and macropinocytosis are both reliant upon normal lysosomal 
acidification to function we indirectly investigated lysosomal pH by monitoring 
autophagy in -secretase mutants. Upon ablation of -secretase components 
Dictyostelium cells show typical acidification defects with longer GFP acidification 
times compared to wild-type cells (King et al., 2013). These data correlate with 
those found in mammalian cells where non-functional -secretase/Presenilin 
results in decreased lysosomal pH, and subsequent dysfunctional protein 
clearance from cells (Lee et al., 2015, Lee et al., 2010, Neely et al., 2011). 
However, whether these functions are reliant upon the entire protein complex, or 
solely the Presenilin proteins is not fully understood, nor is the role of 
catalytic/structural activity (Neely et al., 2011, Lee et al., 2015). This thesis adds 
to the current pool of knowledge by showing that this process relies upon the 
entire -secretase complex and not only the Presenilin proteins. Further, we 
confirm that this function does not rely upon the catalytic activity of the protein 
complex as suggested in mammalian cells (Lee et al., 2015) and show 
conservation between the human and Dictyostelium Presenilin proteins. 
Additionally, we confirm these defects utilising phagocytosis assays (kindly 
carried out by Dr. Jason King) and directly measure proteolysis and acidification. 
In this chapter, we demonstrate that the Dictyostelium -secretase complex is a 
key component in Dictyostelium macropinocytosis and autophagy, and that this 
process may be disrupted due to dysfunctional lysosomal pH mediation. Further, 
we show that these defects are dependent upon having a complete -secretase 
complex as single component null lines share the same defects, and that this 
function is not dependent upon catalytic activity. Finally, we show that these roles 
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are shared between the Dictyostelium and human proteins indicating a 
conservation of function across these two evolutionarily distinct species.  
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Chapter VI 
Discussion 
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 Alzheimer’s disease poses a significant healthcare cost and burden, with 
affected individuals expected to increase as the ageing population grows (Anders 
et al., 2015). The -secretase complex has been associated with Alzheimer’s 
disease progression and has been thoroughly investigated in its proteolytic 
function (De Strooper, 2003, De Strooper et al., 1998, Dries et al., 2009, Luo et 
al., 2003), however evidence suggests a non-catalytic structural function for this 
complex that may also contribute towards Alzheimer’s disease progression and 
pathology (Murayama et al., 1998). conserved throughout evolution (Otto et al., 
2016, Kang et al., 1999, Ludtmann et al., 2014, Khandelwal et al., 2007). This 
study set out to confirm previous controversial -secretase research utilising 
Dictyostelium, and to determine the role of the components that make up this 
protein complex. This study led to the discovery of roles for the Dictyostelium -
secretase complex in endocytosis, and autophagy as shown in mammalian 
model systems (Tamboli et al., 2008, Zhang et al., 2006, Lee et al., 2015, Lee et 
al., 2010, Neely et al., 2011). Additionally, this study set out to investigate whether 
the function of the -secretase complex in this role is as an entire unit, or only the 
presenilin components as previously suggested and the role of catalytic function 
in these processes (Lee et al., 2015).  
6.1 Confirming Previous Research in Dictyostelium 
 Whilst Dictyostelium has been used to investigate the  -secretase 
complex previously (McMains et al., 2010, Ludtmann et al., 2014), little is known 
about the homology between aph-1, ncstn and pen-2 between Dictyostelium and 
humans. Here we have demonstrated that the Dictyostelium -secretase 
components share important motifs and domains across evolution (Chapter III). 
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Dictyostelium Aph-1 shares a common number of transmembrane domains, and 
important motifs between humans and Dictyostelium including the GxxxGxxxG 
utilised for integrating and stabilising Aph-1 into the -secretase complex (Lee et 
al., 2004b). Ncstn also shares an essential stabilising/substrate sensing DYIGS 
motif between several species (Lim et al., 2015), and Pen-2 contains a strongly 
conserved C-terminal sequence (Chapter III).  
Localisation of the -secretase complex in Dictyostelium was not investigated 
prior to this study, although Presenilin was shown to co-localise with calnexin at 
the endoplasmic reticulum (Ludtmann et al., 2014). Here, we confirmed Psen 
localisation to the endoplasmic reticulum, and further showed a similar 
localisation where Aph-1 and Ncstn colocalise with the ER marker calreticulin 
(Chapter III). The localisation of three out of four components to the ER in 
Dictyostelium strongly suggests that this protein complex is localised to the ER in 
this model system is consistent with that in mammals (Fassler et al., 2011). 
However, this localisation utilised overexpression constructs presenting a host of 
difficulties in interpretation (Gahlmann and Moerner, 2014), and therefore future 
studies may utilise knock-in approaches to allow for visualisation and localisation.  
Previous research utilising Dictyostelium to investigate the -secretase complex 
has been controversial. Studies have suggested that the Presenilin, Aph-1 and 
Ncstn components of the -secretase complex function in Dictyostelium 
development (McMains et al., 2010), or that only the Presenilin proteins play a 
role in a non-catalytic manner (Ludtmann et al., 2014). In this study, we confirmed 
that Dictyostelium development in the absence of -secretase components is 
dependent upon the developmental substrate utilised (Chapter IV). psenA-/B- 
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cells demonstrate dysfunctional development under all conditions (McMains et 
al., 2010, Ludtmann et al., 2014), but aph-1- and ncstn- cells develop fully formed 
fruiting bodies on nitrocellulose filters as previously suggested (Ludtmann et al., 
2014), and fail to develop fruiting bodies on 1% KK2 agar plates as demonstrated 
previously (McMains et al., 2010).  This thesis confirms both of the previous 
studies observed developmental phenotypes. 
6.2 The Role of Dictyostelium-secretase in Vesicular Trafficking 
 Dictyostelium has been utilised to investigate a large body of work relating 
to vesicular trafficking including endocytosis (Bloomfield et al., 2015, Chubb et 
al., 2000, Hacker et al., 1997) and autophagy (Calvo-Garrido and Escalante, 
2010, King et al., 2013, King et al., 2011, Otto et al., 2004, Xiong et al., 2015). In 
this thesis we utilised aph-1- cells (Chapter IV), ncstn-, and psenA-/B- cells 
(Ludtmann et al., 2014) to investigate whether the -secretase complex 
functioned in Dictyostelium vesicle trafficking.  
This thesis has shown that in Dictyostelium the entire -secretase complex plays 
a role in macropinocytosis and is required for normal function. Ablation of any of 
the components results in decreased overall macropinocytosis and a decreased 
rate of macropinocytosis (Chapter V). Additionally, we have established that this 
role is not dependent upon the catalytic activity of the protein complex, as 
catalytically inactive Presenilin rescue constructs can restore macropinocytosis 
to wild-type levels. Finally, we show a conservation of function between 
Dictyostelium and human through expression of a human Presenilin in 
Dictyostelium, once again restoring macropinocytosis function regardless of 
catalytic activity.  
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In Dictyostelium research, autophagy mutants exhibit different developmental 
phenotypes dependent upon substrate (Otto et al., 2004). As we demonstrated 
the same phenotypes in cells lacking -secretase components (Chapter III) we 
sought to determine whether these mutants are also exhibit autophagy defects. 
Utilizing the autophagosome marker GFP-Atg8 we have demonstrated for the 
first time that the Dictyostelium -secretase complex exhibits characteristic 
autophagy defects including increased GFP-Atg8 vesicle size, and increased 
levels of high molecular weight ubiquitin (Chapter V). These results show that in 
Dictyostelium the -secretase complex functions to mediate autophagy, although 
it remains unknown if this occurs through a direct or indirect manner. Additionally, 
this process is not reliant upon the catalytic activity of the complex, and is 
evolutionarily conserved between humans and Dictyostelium as shown through 
the use of human Presenilin protein constructs.  
The processes of macropinocytosis and autophagy both converge at the point of 
lysosomal acidification (Hu et al., 2015). Through the use of GFP-quenching 
assays we have indirectly shown that lysosomal acidification in Dictyostelium -
secretase null mutants is dysfunctional (Chapter V). Additionally, we have 
confirmed this role more directly using phagocytic proteolysis assays utilizing DQ-
BSA (Appendix 4, Dr. Jason King). Cells lacking a functional -secretase exhibit 
decreased acidification, and proteolysis, defects that are observed in mammalian 
models for Alzheimer’s disease (Lee et al., 2015, Lee et al., 2010). Additionally, 
we confirm that the process of vesicle acidification is not reliant upon catalytic 
activity, however, in Dictyostelium the process is reliant upon the whole -
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secretase complex being present, and not only the presenilin proteins as 
observed in mammalian cells (Lee et al., 2015).  
In this thesis, we have successfully shown that the Dictyostelium -secretase 
complex is required for normally functioning macropinocytosis and autophagy. 
This dysfunction may be due to defects in acidification of lysosomes which 
therefore affects the processes of autophagy, macropinocytosis and 
phagocytosis downstream, further studies may wish to investigate this 
dysfunction directly. Whilst in mammalian studies it has been suggested that this 
acidification defect is due to dysfunctional calcium homeostasis, however, upon 
restoration of calcium levels cells still exhibited basic lysosomal pH (Lee et al., 
2015). Future studies may wish to investigate whether the localisation and 
function of the v-ATPase pump is altered upon -secretase ablation (Lee et al., 
2010).  Additionally, this thesis has not been able to investigate the function of 
Pen-2 as a component of the -secretase complex. This thesis supports a role for 
the -secretase complex in dysfunctional vesicle acidification as suggested in 
mammalian studies (Lee et al., 2015, Lee et al., 2010), but expands findings to 
show that the entire complex functions in this process and not only the Presenilin 
proteins. Dysfunction in the endocytic pathway is believed to precede Alzheimer’s 
disease pathology and progression (Cataldo et al., 2000), and this process may 
provide alternative therapeutic pathways for the treatment, and prevention of 
Alzheimer’s disease.  
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Appendix 1 Full alignment of Dictyostelium Aph-1 against human, animal, and plant Aph-
1 proteins. Black boxes indicate conserved domains or motifs across all species. Asterisks 
represent identical amino acids, colons represent highly similar amino acids and full stops 
represent similar amino acids. 
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Appendix 2 Full protein alignments of Dictyostelium Nicastrin against human, animal, 
and plant Nicastrin proteins. Black boxes indicate conserved motifs and domains across all 
species. Asterisks represent identical amino acids, colons represent highly similar amino acids 
and full stops represent similar amino acids. 
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Appendix 3. Full protein alignments of Dictyostelium Pen-2 against human, animal, and 
plant Pen-2 proteins. Black boxes indicate conserved motifs and domains across species. 
Asterisks represent identical amino acids, colons represent highly similar amino acids and full 
stops represent similar amino acids. 
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Appendix 4 DQ-BSA acidification in -secretase null mutants. A) Fluorescence of 
phagocytically engulfed DQ-BSA during phagosomal acidification in wild-type, PsenA-/B-, Aph-1-
, PsenA-/B-::PsenB-GFP, PsenA-/B-::PsenBDD-GFP, PsenA-/B-::hPsen1-GFP, PsenA-/B-
::hPsen1DD-GFP cells. PsenA-/B- cells and Aph-1- cells exhibit a decrease in fluorescence upon 
uptake and acidification (error bars = SEM). B) Rate of uptake shows a significant decreased 
(p<0.05) in proteolysis in Aph-1- and PsenA-/B- cells compared to wild-type cells which is 
rescued upon expression of Dictyostelium or human Presenilin. Additionally, catalytically 
inactive mutants (PsenBDD, hPsen1DD) are capable of restoring acidification to wild-type levels 
(p>0.05).  
